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ABSTRACT
THE ROLE OF PHOSDUCIN-LIKE PROTEIN AS A CO-CHAPERONE
WITH THE CYTOSOLIC CHAPERONIN COMPLEX IN THE
ASEMBLY OF THE G PROTEIN βγ SUBUNIT DIMER

Phosducin-like protein (PhLP) has been shown to interact with the cytosolic chaperonin
containing TCP-1 (CCT), and the βγ subunit dimer of heterotrimeric G proteins (Gβγ).
Here we provide details obtained from cryo-electron microscopic and biochemical studies
on the structure of the complex between the cytosolic chaperonin CCT and PhLP.
Binding of PhLP to CCT occurs through only one of the two chaperonin rings, making
multiple contacts with CCT through both its N- and C-terminal domains. In addition, we
show that PhLP acts as a co-chaperonin along with CCT in mediating the assembly of the
G protein βγ subunit and that assembly is dependant upon the phosphorylation of PhLP
by the protein kinase CK2. Variants of PhLP lacking the CK2 phosphorylation sites, or
variants with an inability to bind Gβγ block the assembly process and inhibit G protein
signaling. PhLP forms a complex with CCT and nascent Gβ prior to the release of Gβγ
from the ternary complex and subsequent association with the Gγ subunit to form the Gβγ
dimer. In order to understand the mechanism of Gβγ dimer assembly and the role of
PhLP phosphorylation in the assembly process, we provide here a method for the
purification of the PhLP·CCT·Gβ ternary complex of sufficient purity for structural
studies.
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CHAPTER 1

THE POTENTIAL ROLE OF PHOSDUCIN-LIKE PROTEIN AND THE CYTOSOLIC
CHAPERONIN COMPLEX IN G PROTEIN-MEDIATED SIGNAL TRANSDUCTION.

Eukaryotic cells employ heterotrimeric G proteins to transduce a wide variety of
hormonal, neuronal, and sensory signals that control numerous physiological processes.
As a result, malfunctions in G protein pathways contribute to many diseases (Rockman,
Koch et al. 2002; Simonds 2003; Gainetdinov, Premont et al. 2004), and therapeutic
agents targeting G protein-coupled receptors represent the single largest class of current
pharmaceuticals (Schoneberg, Schulz et al. 2004). There are three fundamental steps in
the propagation of a G protein-mediated signal. First, a ligand binds a receptor, resulting
in a change in the packing of the seven transmembrane α-helices found in all G proteincoupled receptors. Second, the activated receptor catalyzes exchange of GDP for GTP on
the α subunit of a heterotrimeric G protein (Gα) on the intracellular surface of the
receptor. GTP binding causes Gα to dissociate from the G protein βγ subunit complex
(Gβγ). Third, the Gα·GTP and Gβγ complexes control the activity of effector enzymes
and ion channels that regulate the intracellular concentration of second messengers
(cyclic nucleotides, inositol phosphates, and Ca2+) and the plasma membrane electrical
potential (mainly via K+ channels). Changes in these properties in turn orchestrate the
cellular response to the stimulus (Cabrera-Vera, Vanhauwe et al. 2003).

10

Phosducin-like protein (PhLP) is a member of the phosducin gene family (Miles, Barhite
et al. 1993; Flanary, DiBello et al. 2000; Blaauw, Knol et al. 2003) that is believed to
participate in G protein signaling by virtue of its ability to bind the Gβγ dimer with high
affinity (Schroder and Lohse 1996; Thibault, Sganga et al. 1997; Savage, McLaughlin et
al. 2000). Many in vitro and over-expression experiments have shown that PhLP binding
to Gβγ blocks its ability to interact with Gα or effectors (Schroder and Lohse 1996;
Thibault, Sganga et al. 1997; Gensse, Vitale et al. 2000; McLaughlin, Thulin et al. 2002;
Humrich, Bermel et al. 2003). From these experiments, it was suggested that the
physiological role of PhLP was to down-regulate G protein signaling by sequestering
Gβγ. However, the results of several recent studies have seriously challenged this model.
Specifically, disruption of the PhLP1 gene in the chestnut blight fungus cryphonectria
parasitica (Kasahara, Wang et al. 2000) and in the soil amoeba Dictyostelium discoideum
(Blaauw, Knol et al. 2003) yielded the same phenotype as the disruption of the Gβ gene.
Moreover, PhLP deletion blocked G protein signaling in Dictyostelium (Blaauw, Knol et
al. 2003). In another study, the duration of opiate desensitization was prolonged in mice
in which PhLP expression in the brain was inhibited by antisense oligonucleotide
treatment (Garzon, Rodriguez-Diaz et al. 2002). All of these observations are the exact
opposite of what would be predicted by the Gβγ sequestration model.
Further insight into the role of PhLP emerged as studies began to characterize the
interaction of PhLP with a previously unidentified binding partner, the chaperonin
containing tailless complex polypeptide 1 (CCT), a cytosolic molecular chaperone
(McLaughlin, Thulin et al. 2002). Molecular chaperones are a large class of proteins that
assist other proteins in attaining their active conformation. Among them, chaperonins are
11

a ubiquitous family of chaperones that have a common toroidal structure formed by the
oligomerization of eight different 60-kDa subunits. The toroid is made of two rings
placed back-to-back with each ring enclosing a cavity where folding occurs (Ellis, R.J.
1996). Chaperonins have been classically divided in two groups depending on whether
they are found in eubacteria and in the endosymbiotic organelles (group I) (Ellis and
Hartl 1999) or in archaea and the cytosol of eukarya (group II) (Gutsche, Essen et al.
1999). The monomers of every chaperonin known share a very similar three-domain
structure (Braig, Otwinowski et al. 1994; Ditzel, Lowe et al. 1998): an equatorial domain
that contains the nucleotide binding site and most of the interaction sites between the
subunits of the same ring and of the opposite ring; an apical domain where the substrate
binding site is located; and an intermediate domain that transmits to the apical domain the
signals generated in the equatorial domain upon nucleotide binding. Chaperonins act on
unfolded substrates by using a general mechanism that involves the recognition of the
unfolded polypeptide by hydrophobic residues at the entrance of the chaperonin cavity,
followed by folding of the polypeptide upon closure of the cavity induced by the binding
of ATP and a co-chaperonin (Gomez-Puertas, Martin-Benito et al. 2004).
A more specific mechanism seems to operate for the group II eukaryotic cytosolic
chaperonin CCT (chaperonin containing TCP-1), whose toroidal structure is made up of
two rings composed of eight different but homologous proteins (Willison, K.R. 1999).
The work carried out with the major CCT substrates, actin and tubulin, has shown that
the recognition mechanism operates through defined CCT subunits and specific domains
of the substrates, which have already acquired a large degree of native-like conformation
before interacting with CCT. The conformational changes undergone by CCT upon
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nucleotide binding would be used to actively fold the two cytoskeletal proteins (GomezPuertas, Martin-Benito et al. 2004) or to generate a structure apt to form a stable complex
with other proteins (Valpuesta, J.M. 2004). In addition to its involvement in actin and
tubulin folding, various other substrates have been characterized, including many WD40
repeat, 7-bladed β-propeller proteins. Among these various substrates, PhLP and more
recently, the G protein β subunit have been shown to bind CCT (Lukov, Hu et al. 2005;
Wells, Dingus et al. 2006). The focus of this thesis is to gain a better understanding of the
functional consequences of the interactions of PhLP with its binding partners CCT, Gβγ,
and the Gβ subunit.
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CHAPTER 2

STRUCTURE OF THE COMPLEX BETWEEN THE CYTOSOLIC
CHAPERONIN CCT AND PHOSDUCIN-LIKE PROTEIN.
Introduction–The interaction between PhLP and CCT appears to play a different role than
that of a protein substrate being folded by a chaperonin. PhLP and its homologue Pdc are
involved in the regulation of cell signaling through their interaction with the Gβγ.
Binding of PhLP or Pdc prevents Gβγ from interacting with the Gα subunit or
downstream effectors (Bauer, Muller et al. 1992; Lee, Ting et al. 1992; Hawes, Touhara
et al. 1994; Gaudet, Bohm et al. 1996; McLaughlin, Thulin et al. 2002). Unlike protein
folding substrates, PhLP has been shown to interact with CCT in its native form and to
inhibit its actin folding activity (McLaughlin, Thulin et al. 2002), suggesting that PhLP
may be a regulator of CCT activity or conversely that CCT could control the availability
of PhLP during G protein signaling (McLaughlin, Thulin et al. 2002).
To gain further insight into the interaction between CCT and PhLP, we have carried out
biochemical analysis of the CCT·PhLP complex. Three-dimensional reconstruction of
CCT·PhLP obtained by cryoelectron microscopy together with binding experiments
performed with various PhLP mutants has led to the determination of the regions of PhLP
and the subunits of CCT involved in the formation of the CCT·PhLP complex, and to an
hypothesis of the physiological function of the CCT·PhLP interaction.
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EXPERIMENTAL PROCEDURES

Protein preparation – CCT was purified from soluble extracts of bovine testis as
described (Martín-Benito, Boskovic et al. 2002). Gβ1γ1 was purified from bovine retina
and recombinant rat PhLP, and the PhLP/Pdc chimeric proteins were expressed and
purified from Escherichia coli as described (Savage, McLaughlin et al. 2000). The
CCT·PhLP complexes were formed by incubating CCT and PhLP in a 1:10 molar ratio
for 30 min at 25°C. In the case of the CCT·PhLP·antibody immunocomplexes, preformed
CCT·PhLP complexes were incubated with anti-CCTδ 8g monoclonal antibody (5:1
antibody:complex molar ratio) for 15 min at 25°C.

Generation of PhLP/Pdc chimeras – The cDNA for wild-type rat PhLP and Pdc with a 3´
c-myc epitope tag were previously constructed in the pET15b vector (McLaughlin,
Thulin et al. 2002). The PhLP/Pdc chimeras were made by PCR amplification of two
PhLP cDNA fragments from this vector. The fragments were divided at an endonuclease
restriction site within the Pdc sequence to be inserted or the PhLP sequence near the
replacement point. If the restriction site was within the Pdc insert, fragments were
amplified with primers complimentary to the sequence of PhLP at the replacement point
with overhangs containing the Pdc sequence including the restriction site. If there was no
restriction site within the Pdc insert, then a primer containing complementary nucleotides
of PhLP next to the replacement point, the entire Pdc sequence to be inserted, and the
additional PhLP sequence up to the restriction site was used. The other primer was
complementary to PhLP sequence including the restriction site. Each fragment was then
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amplified by pairing these primers with either the T7 forward or reverse primers from
pET15b flanking the PhLP cDNA. The fragments were cut at the restriction site, gel
purified, and ligated. The full-length chimeras were then PCR-amplified by using the T7
forward and reverse primers and inserted into the pET15b vector by using the NcoRI and
BamHI restriction sites. For the P193R chimera, the single amino acid substitution was
made by using the QuikChange protocol (Stratagene). All constructs were confirmed by
DNA sequence analysis.

Binding of PhLP/Pdc chimeras to CCT – Binding of the PhLP/Pdc chimeras to CCT was
measured by co-immunoprecipitation and immunoblotting. Purified PhLP/Pdc chimeric
proteins (250nM) were added to 10% rabbit reticulocyte lysate in PBS with 0.5mM
PMSF and 0.5% Igepal CA-630 detergent (Sigma) in a 100 µl total volume and incubated
for 15 min at 4°C. PhLP/Pdc complexes were immunoprecipitated by using an antibody
to the C-terminal c-myc tag fused to each chimera and immunoblotted with an antibody
to CCTα or Gβγ as described (McLaughlin, Thulin et al. 2002). Intensities of the CCTα
bands from the PhLP/Pdc chimera were expressed as a percentage of the CCTα band
intensity from the wild-type PhLP immunoprecipitates.

Electron microscopy – All cryoelectron microscopy methods were performed in the
laboratory of Dr. Jose M. Valpuesta at the Universidad Autonoma de Madrid, Spain. For
cryoelectron microscopy, 5 µl aliquots of a solution containing CCT·PhLP complexes
were applied to glow-discharged holey carbon grids for 1 min, blotted for 5 sec, and
frozen rapidly in liquid ethane at -180°C. Images were recorded at 20° tilt under
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minimum dose conditions in a FEI G2 FEG electron microscope equipped with a Gatan
cold stage operated at 200 kV and recorded on Kodak SO-163 film at X62,000 nominal
magnification and between 1.5 and 2.5 µm underfocus. For electron microscopy of
negatively stained samples, 5 µl aliquots were applied to glow-discharged carbon grids
for 1 min and then stained for 1 min with 2% uranyl acetate. Images were recorded at 0°
tilt in a JEOL 1200EX-II electron microscope operated at 100 kV and recorded at
X60,000 nominal magnification.

Image processing, two-dimensional averaging and three-dimensional reconstruction–
Micrographs were digitized in a Zeiss SCA1 scanner with a sampling window
corresponding to 3.5 Å per pixel for vitrified samples. For two-dimensional classification
and averaging, top and side views of CCT particles were selected, aligned by using a
free-pattern algorithm, and classified by using self-organizing maps as described (MartínBenito, Boskovic et al. 2002) to separate the PhLP-bound CCT particles from those free
of PhLP. The three-dimensional reconstruction of the CCT·PhLP complex was
generated from randomly oriented particles whose orientation was determined by using
the angular refinement algorithms provided by Spider (Frank 1996). The volumes were
generated by using the back-projection method (Guex and Peitsch 1997). No
symmetrization was applied to any of the volumes obtained during the iterative
procedure. The final resolution was estimated with the 0.5 criterion for the Fourier shell
correlation coefficient between two independent reconstructions by using BSOFT
(Heymann 2001). Visualization of the volumes was carried out by using AMIRA
(http://amira.zib.de).
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Modeling of PhLP and docking of the CCT·PhLP complex – The atomic model of PhLP
was generated by homology modeling techniques using the sequences and atomic
structures of four Pdc proteins (PDB ID codes 2TRC, 1AOR, 1B9Y, and 1B9X) with the
DALI comparison algorithm (Holm and Sander 1993) at the SWISS-MODEL server
facilities (Guex and Peitsch 1997) (http://swissmodel.expasy.org//SWISS-MODEL.html).
The atomic model of PhLP was then fitted manually into the three-dimensional
reconstruction of the CCT·PhLP complex by using O (Jones, Zou et al. 1991).

RESULTS AND DISCUSSION

The formation of the CCT·PhLP complex –To confirm the reported interaction of PhLP
with CCT and to visualize the CCT·PhLP complexes, purified CCT was incubated in the
absence or presence of a 10 molar excess of purified PhLP, and the samples were stained
as described in Experimental Procedures. Two typical views were observed under the
electron microscope: the most common top view revealing the octameric nature of the
CCT rings, and the less frequent side view showing the two-ring structure of the
chaperonin. The latter view turned out to be the most informative in detecting the absence
(Fig. 1A) or the presence of PhLP bound to the chaperonin oligomer (Fig. 1B), which
seems to occur outside the folding cavity. PhLP protrudes from the apical region of the
chaperonin in a manner similar to the interaction between CCT and its cochaperonin
prefoldin (PFD) (Martin-Benito, Boskovic et al. 2002). However, unlike what happens
with PFD, the side views of the CCT·PhLP complex indicate that the interaction between
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PhLP and CCT occurs with only one of the chaperonin rings, regardless of the amount of
PhLP added to the CCT solution, confirming the predicted 1:1 stoichiometry for the
CCT·PhLP complex (McLaughlin, Thulin et al. 2002).

Fig. 2-1. Two dimensional average images of negatively stained CCT·PhLP complex. (A) Average
image of side views obtained from 243 CCT particles of apo-CCT. (B) Average image obtained from
286 side views of CCT·PhLP complexes. (C) Average image obtained from 4,225 top views of
CCT·PhLP complexes. (D and E) Average images of the two types of top views of CCT·PhLP·8g
(anti-CCTδ) immunocomplexes (average of 324 and 626 particles). The subunit labeled by the
antibody is marked with ˝δ˝ (Scale bar, 100 Å) A schematic model of each mode of PhLP binding,
with the topology of the CCT subunits accompanies each average image.

CCT subunits involved in PhLP binding–The side view of the CCT·PhLP complex
depicted in Fig. 1B also suggests the interaction of PhLP with regions on opposite sides
of the CCT cavity. This orientation is confirmed by the average top view image of the
same complex (Fig. 1C), which shows that an asymmetric mass traverses the chaperonin
cavity and interacts with two CCT subunits on one side of the cavity and three CCT
subunits on the other side. This interaction is geometry-dependant, similar to what has
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already been described for actin (Llorca, McCormack et al. 1999) and tubulin (Llorca,
Martín-Benito et al. 2000). To determine whether the interaction is also subunit-specific
we made use of a monoclonal antibody reacting against the CCTδ subunit (8g) (Llorca,
McCormack et al. 1999). Aliquots of the immunocomplexes were negatively stained (to
contrast only one of the CCT rings), and 950 top views were processed. After the
classification procedures, two main populations were obtained with PhLP present in the
CCT cavity whose average images are represented in Fig. 1D and E, respectively. Both
images reproduce a similar mass crossing the CCT cavity. The specificity of the
monoclonal antibody and the known topology of the CCT ring (Liou and Willison 1997)
allowed determination of the CCT subunits involved in PhLP binding. The average image
shown in Fig. 1D represents 65% of the CCT·PhLP complexes and points to an
interaction of PhLP with CCTγ/θ on one side of the CCT cavity and CCTα/ε/ζ on the
other side. In the average image representing the remaining 35% of the CCT·PhLP
complexes (Fig. 1E), PhLP seems to interact with CCTδ/η on one side of the cavity and
CCTζ/β/γ on the other side. The structural basis for these two different modes of
interaction and their physiological relevance remains to be determined. Nevertheless, in
either structure PhLP binding occludes the CCT cavity, possibly explaining why PhLP
competes with other substrates for their interaction with CCT and therefore regulates the
chaperonin folding activity (McLaughlin, Thulin et al. 2002).

Three-dimensional structure of the CCT·PhLP complex–To further characterize the
interaction between PhLP and the cytosolic chaperonin, a three-dimensional
reconstruction of the CCT·PhLP complex was carried out by cryoelectron microscopy
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and image processing. After image classification, a homogenous population of 2,625
particles was obtained and used to generate a three-dimensional reconstruction of the
CCT·PhLP complex (Fig. 2A and B). The reconstruction reveals an asymmetric bulletshaped structure as was observed in the two-dimensional average image of the side view
of the same complex (Fig. 1B). Compared with the three-dimensional reconstruction of
apo-CCT (Fig. 2C), the CCT·PhLP complex shows important differences, especially in
the PhLP-bound CCT ring. One difference has to do with the mass clearly attributed to
PhLP that sits at the entrance of the cavity and protrudes from it. In contrast to the
interaction of CCT with actin (Llorca, McCormack et al. 1999), tubulin (Llorca, MartínBenito et al. 2000), or its cochaperone, PFD (Martin-Benito, Boskovic et al. 2002), no
part of the PhLP mass penetrates into the folding cavity but simply interacts with two
opposite sides of the top apical region. The level of resolution of the CCT·PhLP complex
(26Å) allows visualization of the PhLP mass as a two-domain structure connected by a
small linker. The two domains are clearly asymmetric, the small one interacting with two
CCT subunits and the large one with three subunits (Fig. 2A). Another difference is a
PhLP-induced movement of the apical domains of the CCT subunits, reducing the
diameter of the entrance of the folding cavity from ≈80 Å to ≈55 Å and leaving the
entrance almost occluded by the presence of PhLP (Fig. 2A). This finding confirms the
flexibility of the apical domains, which are capable of undergoing large conformational
changes within the functional cycle and of accommodating substrates of different sizes
(Grantham, Llorca et al. 2000). These large conformational changes of the apical
domains induced by PhLP suggest a high-affinity interaction, consistent with the 190 nM
Kd reported (McLaughlin, Thulin et al. 2002). The high binding affinity appears to derive
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from a concerted action of the two PhLP domains and all eight CCT subunits, probably
involving multiple contacts. Finally, the reconstruction also confirms the binding of PhLP
to only one of the CCT rings (McLaughlin, Thulin et al. 2002) and strongly suggests that
the movement of the apical domains in the PhLP-bound ring transmits an allosteric signal
through the equatorial domains so that no PhLP molecule is able to bind to the opposite
ring.

Fig. 2-2. Three-dimensional reconstruction of the CCT·PhLP complex by cryoelectron
microscopy. (A) Top view of the CCT·PhLP complex. (B) Side view of the same volume. (C) Side
view of the three-dimensional reconstruction of apo-CCT.

Docking analysis of PhLP into the three-dimensional structure of the CCT·PhLP
complex–PhLP belongs to a family of widely expressed regulators of G protein signaling
(Schroder and Lohse 2000). Although no atomic structure is available for PhLP, there is a
high degree of sequence homology between PhLP and Pdc (41% amino acid identity)
(Miles, Barhite et al. 1993), another member of the family for which several atomic
structures are available (Gaudet, Bohm et al. 1996; Loew, Ho et al. 1998; Gaudet, Savage
et al. 1999). This similarity allowed us to generate an atomic model of PhLP by
homology modeling techniques (see materials and methods). The atomic model (Fig.3)
lacked the first 50 residues of the rat PhLP sequence, which are not present in Pdc, and
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the last 24 residues not defined in the atomic structures of Pdc. The model naturally
shows very similar structural features to the Pdc atomic structure (Figure 3B): an
unstructured N-terminal domain built up by three α-helices (H1–H3) and a more compact
C-terminal domain showing a typical thioredoxin fold (Martin 1995; Gaudet, Bohm et al.
1996), with a core formed by a five-stranded β-sheet (S1–S5) flanked by four α-helices
(H4–H7). The two domains are linked by a flexible loop that connects H3 and S1.
A docking analysis was carried out by fitting the atomic model of PhLP into the mass of
the CCT·PhLP complex attributable to PhLP (Fig. 3). The fit is very good only when the
C-terminal domain is assigned to the smaller, more compact of the two PhLP masses of
the reconstructed volume. The N-terminal domain fits well into the larger mass, and
although there is a portion of the mass that is not filled, this could be attributed to the 50
residues of the N-terminal domain not present in the atomic model (red arrow in Fig. 3B).
An analysis of the docking results suggests the involvement of several regions of PhLP in
the binding of CCT (Fig. 3B and 3C). In the N-terminal domain, a large stretch of amino
acids runs parallel to the apical domains of the three CCT subunits that are in close
proximity to PhLP (Fig. 3C) and suggests a possible binding interface (Fig. 4A). This
region (K109–E135) encompasses part of the long H1–H2 loop, H2, the H2–H3 loop, and
the N-terminal part of H3. In addition, the 50 N-terminal residues not present in the
atomic model could potentially be involved in CCT binding through an interaction with
the third CCT subunit (red arrow in Fig. 3B). In the C-terminal domain, three regions are
likely candidates for interaction with the two CCT subunits (Fig. 3B and C), the loops
between S2 and H5 (E189–G194), H6 and S4 (G223–N231), and S5 and H7 (V249–D258).
Additionally, part of the last 24 residues of the sequence, not present in the atomic model,
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might be placed in the bottom part of the PhLP mass and therefore could also be involved
in CCT binding. In all, the electron microscopy shows clearly that both domains of PhLP
are involved in CCT binding, and the docking of the atomic model of PhLP into the
three-dimensional reconstruction of the CCT·PhLP complex points to several specific
regions of both N- and C-terminal domains of PhLP as involved in CCT binding.

Fig. 2-3. Docking of the atomic model of PhLP into the three-dimensional reconstruction of the
CCT·PhLP complex. (A) Docking of the atomic model of PhLP into the CCT·PhLP volume. (B and
C) Two enlarged views of the docking of the PhLP atomic model (drawn in tubes) into the CCT·PhLP
complex (depicted in transparent fashion). The red arrow in B indicates a region of the PhLP mass that
could be filled by the 50 residues of the N-terminal sequence of PhLP not present in the PhLP atomic
model. The green regions in the atomic model of PhLP are those suggested by the docking analysis to
be involved in CCT binding.

Biochemical analysis of the CCT-PhLP interaction–To assess the validity of this
structural model of the PhLP-CCT interaction, the binding properties of a set of chimeric
proteins were generated in which the PhLP sequences implicated in CCT binding by the
cryo-EM studies (Martin-Benito, Bertrand et al. 2004) were replaced with the
corresponding Pdc sequence. This mapping strategy takes advantage of the fact that
although both proteins are homologous, only PhLP interacts with CCT (McLaughlin,
Thulin et al. 2002). A set of two chimeras was generated in which the N-terminal
(residues 1–153) and C-terminal (residues 154–301) domains of PhLP were switched
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with the corresponding region of Pdc (Fig. 4A). The two chimeras were then assayed for
CCT and Gβγ binding by co-immunoprecipitation and immunoblotting, the latter serving
as a control for the ability of the chimeras to maintain their functional activity and
therefore their native conformation. The results in Fig. 4B show that neither chimera
binds CCT yet both are able to bind Gβγ, indicating that both the N- and the C-terminal
domains of PhLP are required for CCT binding. The diminished Gβγ binding of
PhLP/Pdc(1–153) is anticipated, given the fact that the N-terminal domain of PhLP
contributes more to Gβγ binding than that of Pdc, and that the C-terminal domain of
PhLP contributes less than the homologous region of Pdc (Savage, McLaughlin et al.
2000). These results clearly confirm the structural data showing that contacts from both
N- and C-terminal domains of PhLP are required for CCT binding.

Fig. 2-4. Both domains of PhLP participate in CCT binding. A sequence of alignment of rat Pdc,
PhLP1, PhLP2, and PhLP3 is shown in A. Conserved residues are indicated with gray boxes, and
secondary structural elements for Pdc (Gaudet, Bohm et al. 1996) are indicated above the sequence (H
for helix and S for β-strand). Shaded boxes below the structural elements represent regions implicated
in CCT binding by the docking analysis. A vertical arrow at residue 154 marks the loop between the
N- and C-terminal domains. The PhLP/Pdc(154–301 chimera contains the N-terminal domain of PhLP
and the C-terminal domain of Pdc and Vice versa for the PhLP/Pdc(1–153) chimera. In B, the binding
of these proteins to CCT or Gβ was determined by immunoprecipitation of the PhLP chimeras and
immunoblotting for CCTα and Gβ as described in Materials and Methods. Immunoblots show
representative data from three separate experiments. Positions of molecular weight standards are
shown on the right.
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The next step was to investigate in detail which specific regions of PhLP are involved in
CCT binding, using the information provided by cryo-EM studies (Martin-Benito,
Bertrand et al. 2004). Several PhLP/Pdc chimeric proteins were generated in both N- and
C-terminal domains of PhLP and were also assayed for CCT and Gβγ binding (Figs. 5
and 6).

In the N-terminal domain, six PhLP/Pdc chimeric proteins were designed to cover most
of the secondary structures elements of this domain (Fig. 5A): PhLP/Pdc(60–73), in
which the putative H1 of PhLP had been switched to the corresponding Pdc sequence;
PhLP/Pdc(76–117) and PhLP/Pdc(95–115), covering all or only the C-terminal half of
the H1–H2 loop respectively; PhLP/Pdc(116–132), encompassing the last few residues of
the H1–H2 loop, H2, and the H2–H3 loop; PhLP/Pdc(130–136), covering the H2–H3
loop and the three N-terminal residues of H3; and finally, PhLP/Pdc(138–154),
encompassing H3. The CCT binding assay with the PhLP/Pdc(60–73) chimera showed
no decrease with respect to wild-type PhLP (Fig. 5B), consistent with cryo-EM studies
showing no interaction of H1 with CCT. Binding assays with chimeras PhLP/Pdc(76–
117), PhLP/Pdc(95–115), and PhLP/Pdc(116–132) revealed a small decrease in the
interaction with the chaperonin (≈20-30%), indicating that the H1–H2 loop, H2, and the
N-terminal part of the H2–H3 loop individually make only minor contributions to
chaperonin binding. The CCT binding assays with chimeras PhLP/Pdc(130–136) and
PhLP/Pdc (138–154) showed a complete suppression of chaperonin binding. The
combined information obtained from chimeras PhLP/Pdc(116–132), PhLP/Pdc(130–136),
and PhLP/Pdc(138–154) points to H3 and the C-terminal part of the H2–H3 loop as
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critical for CCT binding (Fig.5) According to cryo-EM studies, the H2–H3 loop and the
N-terminal part of H3 make contact with CCT. In the PhLP/Pdc(130–136) chimera, three
nonconservative changes, L131K, E135G, and F136G, abolish CCT binding (Fig. 5),
suggesting that the stretch of negative charge D132DEE surrounded by hydrophobic
residues is required for CCT binding. Furthermore, in the PhLP/Pdc(138–154) chimera,
H3 residues Q138Q that are on the same side of H3 as E134E are replaced with R and K,
respectively, increasing the positive charge in this face of H3 (Fig. 5). Interestingly, the
negatively charged character of this region is conserved in other PhLP members like
PhLP2 and PhLP3 (Fig. 4A), which are also believed to interact with CCT (Lacefield and
Solomon 2003; Aloy, Böttcher et al. 2004). Indeed, replacement of the D132DEE stretch
with alanines in human PhLP abolishes its CCT binding ability (data not shown). Thus, it
appears that the negatively charged stretch in the H2–H3 loop and at the N terminus of
H3 is critical for CCT binding.

In the C-terminal domain, five chimeras were generated based on the information
extracted from the docking analysis (Fig. 6A) They were PhLP/Pdc(P193R), in which
only a single mutation was necessary to generate the Pdc sequence for the S2–H5 loop;
PhLP/Pdc(223–234), encompassing the H6–S4 loop;PhLP/Pdc(249–260), encompassing
the S5–H7 loop; and PhLP/Pdc(223–234/249–260), a double-loop chimera switching
both of these two later loops. A fifth chimera, PhLP/Pdc(277–301), covered the last 24
residues of the PhLP sequence, a region whose structure was not predicted by the
homology modeling experiment but which could be potentially involved in chaperonin
binding. The CCT binding assays (Fig. 6B) revealed a 60% decrease in chaperonin
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binding for PhLP/Pdc(P193R) compared with wild-type PhLP, suggesting that residue
P193 is involved in the interaction with CCT, probably through the maintenance of a
certain local conformation.

Fig. 2- 5. Binding of PhLP/Pdc chimeras
within the N-terminal domain to CCT.
Chimeras of PhLP within the N-terminal
domain were made by inserting Pdc sequence
as shown in A. The numbers indicate the
residues of PhLP that were replaced with the
corresponding Pdc residues and conserved
residues within the replacements are located
in gray boxes. Binding of these PhLP
chimeras to CCT or Gβγ was measured as in
Fig. 4. (B) Representative immunoblots for
CCTα and Gβ, as well as a graphical
representation of the CCTα binding data
normalized to wild-type PhLP. Bars represent
the mean ± standard error from seven
separate experiments. No PhLP was added to
the blank sample. The standard lanes contain
700 ng of purified CCT (90 ng of CCTα) or
25 ng of Gβγ (21 ng of Gβ).

Fig. 2-6. Binding of PhLP/Pdc chimeras
within the C-terminal domain to CCT.
Chimeras of PhLP within the C-terminal domain
were made by inserting Pdc sequence in the
loops between the predicted secondary structural
elements as shown in A. The numbers indicate
the residues of PhLP that were replaced with the
corresponding Pdc residues and conserved
residues within the replacements are located in
gray boxes. Binding of these PhLP chimeras to
CCT or Gβγ was measured as in Fig. 4. (B)
Representative immunoblots for CCTα and Gβ,
as well as a graphical representation of the
CCTα binding data normalized to Wild-type
PhLP. Bars represent the mean ± standard error
from six separate experiments. The lanes contain
the same amounts of protein as in Fig. 5.
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Other binding assays showed a small 25% increase in binding with PhLP/Pdc(223–234)
and a large 80% decrease in binding with chimera PhLP/Pdc(249–260). A similar 80%
decrease was observed for the double-loop chimera PhLP/Pdc(223–234/249–260). These
results indicate that the H6–S4 loop is not involved in CCT interaction, whereas the S5–
H7 loop has an important role in chaperonin binding. In the PhLP/Pdc (249–260)
chimera, there is only one nonconservative substitution (R250S; Fig. 6A), suggesting that
the positive charge at R250 plays a role in CCT binding. Replacement of the last 24
residues of the C-terminal domain of PhLP with Chimera PhLP/Pdc(277–301) generated
a significant 50% decrease in CCT binding, suggesting that this region is also involved in
the interaction with the chaperonin.
These biochemical data are generally consistent with the structural model proposed from
the docking analysis, confirming most of the suggested contacts and clearly showing that
PhLP interacts with CCT through specific regions in both N- and C-terminal domains. In
all, the CCT binding experiments shown here suggest that apart from the stringent
binding site in the region encompassing part of the H2–H3 loop and H3, PhLP interacts
with CCT through the concerted interaction of several regions of both N- and C-terminal
domains, similar to what has been described for actin and tubulin (Llorca, McCormack et
al. 1999; Llorca, Martín-Benito et al. 2000).
As mentioned earlier, the CCT·PhLP structure displays an interesting similarity to that of
the CCT·PFD complex (Martín-Benito, Boskovic et al. 2002) in that PhLP sits above the
CCT folding cavity, contacting the apical domains of the CCT subunits and occluding the
entrance into the cavity. The function of the co-chaperone PFD is to assist in the folding
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of actin and tubulin by binding to their nascent polypeptide chains and delivering them to
CCT for folding into their native structures (Martín-Benito, Boskovic et al. 2002).
Several lines of evidence suggest a similar role of PhLP with regard to Gβγ folding
and/or assembly. First, genetic deletion of PhLP in Dictyostelium discoideum blocked G
protein signaling and membrane localization of the Gβγ complex (Blaauw, Knol et al.
2003). According to these authors, PhLP could be involved in facilitating the correct
folding of Gβ or its assembly into the Gβγ complex. Second, the need of chaperones for
the correct folding of WD40 proteins like Gβ has been already demonstrated (Clapham
and Neer 1993; García-Higuera, Gaitatzes et al. 1998). Interestingly, the interaction of
some of these WD40 proteins with CCT has also been described, and a folding role of
CCT has been demonstrated for some of them (Camasses, Bogdanova et al. 2003;
Siegers, Bölter et al. 2003). In fact, CCT seems to interact with at least 17% of the yeast
WD40 proteins including Ste4, the yeast Gβ subunit (Valpuesta, Martín-Benito et al.
2002). Third, a proteomic analysis of the protein complexes in yeast revealed an
interaction between CCT, yeast PhLP2, and VID27, a Gβ protein homologue (Aloy,
Böttcher et al. 2004). Fourth, a recent genetic study reveals that the co-chaperoning role
of PhLP with respect to CCT could be extended to the folding of β-tubulin (Lacefield and
Solomon 2003). In light of these data, it is tempting to suggest that PhLP acts as a cochaperone in concert with CCT to catalyze the folding of Gβ proteins and/or assembly of
the Gβγ complexes.
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CHAPTER 3
CK2 MEDIATED ASSEMBLY OF G PROTEIN βγ SUBUNITS BY PHOSDUCINLIKE PROTEIN
Introduction–Insight into an alternative function of PhLP has come from the observation
that PhLP interacts with the cytosolic chaperonin tailess complex polypeptide 1 (CCT),
an essential molecular chaperone that mediates the folding of actin, tubulin, and other
proteins into their native structures (McLaughlin, Thulin et al. 2002). PhLP was shown to
interact with CCT as a regulator and not as a folding substrate. In addition, the
cryoelectron microscopic structure of the PhLP·CCT complex (Martin-Benito, Bertrand
et al. 2004) shows that PhLP binds CCT at the top of the CCT apical domains positioned
above the folding cavity in a manner analogous to prefoldin, a CCT co-chaperone that
binds nascent actin polypeptide chains and delivers them to CCT for folding (MartinBenito, Boskovic et al. 2002). Coupling these observations with the fact that yeast Gβ
(Ho, Gruhler et al. 2002) and other proteins with seven β-propeller structures similar to
Gβ (Valpuesta, Martín-Benito et al. 2002; Camasses, Bogdanova et al. 2003; Siegers,
Bolter et al. 2003) interact with CCT suggests that PhLP might function as a cochaperone in the folding of Gβ. Indeed, recent findings show that PhLP does act as an
essential chaperone for Gβγ dimer assembly (Lukov, Hu et al. 2005). Specifically, these
studies showed that when the expression of PhLP was reduced by 90% in siRNA treated
cells, Gβ expression was inhibited by 40% while Gβ mRNA levels remained unaffected.
In addition, the siRNA-mediated depletion of PhLP adversely affected G protein
signaling, causing a 60% reduction in histamine-induced influx of Ca2+ into the cytosol
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via a classical Gq-mediated cascade. This reduction in G protein signaling resulted from a
decrease in Gβγ assembly in the absence of PhLP. Depletion of PhLP caused a 5-fold
decrease in the rate of Gβγ dimer assembly while PhLP over-expression increased Gβγ
assembly by 4-fold. Interestingly, over-expression of a truncation of PhLP in which
residues 1–75 were deleted (PhLP ∆1–75) revealed that an interaction of PhLP with Gβγ
is vital for assembly of the Gβγ dimer. This variant lacks Helix 1, which is known to
make a substantial contribution to Gβγ binding (Gaudet, Bohm et al. 1996), yet it retains
regions known to interact with CCT (Martin-Benito, Bertrand et al. 2004). This result
suggests that a high-affinity binding of PhLP with Gβγ is vital for assembly of the Gβγ
dimer but that a high affinity binding of PhLP to CCT may not be necessary when PhLP
is overexpressed.
Phosphorylation of PhLP by protein kinase CK2 (CK2) plays an important role in PhLP
function. A major site of CK2 phosphorylation occurs within a sequence of three
consecutive serines (residues 18–20) near the N-terminus (Humrich, Bermel et al. 2003).
Phosphorylation of serines 18–20 was required for PhLP-mediated Gβγ assembly, for
when these residues were substituted with alanine, PhLP was unable to catalyze Gβγ
dimer formation (Lukov, Hu et al. 2005). The mechanism by which phosphorylation at
these sites enhances Gβγ dimer formation is not known; therefore, the effects of CK2
phosphorylation on PhLP function were investigated. The results of these studies provide
evidence for a mechanism of PhLP-mediated Gβγ assembly that involves the formation
of a ternary complex between PhLP, the nascent Gβ polypeptide, and CCT. PhLP
phosphorylation is required for the release of PhLP·Gβ from the CCT complex and the
subsequent association of Gγ with Gβ to form the Gβγ dimer. These findings demonstrate
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that the physiological function of PhLP is not to down-regulate G protein signaling by
sequestering Gβγ but to support G protein signaling by acting as a co-chaperone with
CCT in catalyzing Gβγ dimer formation.

EXPERIMENTAL PROCEDURES
Cell Culture – HEK-293 cells and CHO cells were cultured in Dulbecco’s modified
Eagle’s medium/F-12 (50/50 mix) growth media with L-glutamine and 15 mM HEPES,
supplemented with 10% fetal bovine serum (HyClone). The cells were subcultured
regularly to maintain active growth but were not used beyond 20–25 passages.
Preparation of cDNA constructs – Wild-type human PhLP, PhLP ∆1–75, and Pdc with 3´
c-myc and His6 tags in the pcDNA3.1/myc-His B vector (Invitrogen) were prepared as
described (Lukov, Hu et al. 2005). Serine-to-alanine variants of human PhLP at positions
18, 19, 20, 25, and 296 were constructed in the pcDNA3.1/myc-His B vector by
employing a PCR-based strategy and utilizing unique endonuclease restriction sites near
the substitution site as described (Lukov, Hu et al. 2005). The constructs were then
subcloned into the bacterial expression vector pET15b (Novagen) as described (Carter,
Southwick et al. 2004). The integrity of all constructs was confirmed by sequence
analysis.
Protein expression and purification – Wild-type and CK2 phosphorylation site variants
of human PhLP in the pET15b vector were transformed in Escherichia coli DE3 cells and
were purified using non-denaturing Ni2+ affinity chromatography as described previously
(Savage, McLaughlin et al. 2000). The purified proteins were concentrated and
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exchanged into 20 mM HEPES, pH 7.2, 150 mM NaCl by ultracentrifugation and were
stored in 50% glycerol at –20°C. Protein concentrations were determined using
Coomassie Plus protein assay reagent (Pierce), and the purity was determined to be ~95%
by SDS-PAGE.
CK2 phosphorylation of PhLP – Purified PhLP (50µM) was phosphorylated by CK2 (10
units/µl, Calbiochem) in 20 mM HEPES, pH 7.5, 100 mM KCl, 20 mM NaCl, 5 mM
dithiothreitol, and 1 mM ATP for 1 hr at 37°C. The phosphorylation was confirmed by
SDS-PAGE using 10% gels.
Assay of PhLP binding to CCT – The binding of CK2 phosphorylated PhLP and its CK2
phosphorylation site variants to CCT was measured by adding 5 nM purified PhLP to 5%
rabbit reticulocyte lysate in phosphate-buffered saline containing 1.2% IGEPAL CA-630
(Sigma) and 0.6 mM phenylmethylsulfonyl fluoride in a total volume of 300 µl. Binding
was allowed to proceed for 30 min at 23°C after which the PhLP was
immunoprecipitated by incubating for 30 min at 4°C with 2.1 µg of anti-c myc antibody
(clone 9E10, Biomol) followed by the addition of 30 µl of a 50% slurry of Protein A/G
Plus-agarose beads (Santa Cruz Biotechnology) and another 30-min incubation at 4°C
with constant mixing. The beads were washed with the phosphate-buffered
saline/IGEPAL buffer, and proteins were solubilized with 20 µl of 2X SDS-PAGE
sample buffer. 15 µl of each sample was resolved on a 10% SDS-PAGE gel and was
immunoblotted with a 1:1000 dilution of rabbit polyclonal anti-CCTε antiserum (MartinBenito, Bertrand et al. 2004) followed by a 1:2000 dilution of goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (Calbiochem). Immunoblots were developed
with the ECL Plus chemiluminescence reagent (GE Healthcare) and visualized with a
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storm 860 PhosphorImager (Amersham Biosciences). The band intensities were
quantified using Image-QuaNT software (Amersham Biosciences).
Assay of PhLP inhibition of Gt binding to rhodopsin – Light-induced binding of 0.2 µM
125

I-labeled Gtα and 0.2 µM Gtβγ to membranes containing 1 µM rhodopsin ± 2 µM CK2

phosphorylated or unphosphorylated PhLP was measured as described previously
(Savage, McLaughlin et al. 2000).
Mass spectrometric analyses – Tryptic peptides of CK2-phosphorylated PhLP were
generated and analyzed as described previously (Carter, Southwick et al. 2004). Briefly,
molecular ions in the effluent from a C18 capillary chromatography that correspond to
the predicted masses of phosphopeptides from PhLP were fragmented by collisioninduced dissociation in a Q-ToF mass spectrometer (LC/MS/MS). Fragmentation spectra
were obtained using either automated or manual parent ion selection. Data were analyzed
using BioAnalyst software (Applied Biosystems, Farmingham, MA).
Electrophoretic mobility determinations – CHO cells were plated in 6-well plates so that
they were 70–80% confluent the next day. The cells were then transfected with 1 µg of
either wild-type PhLP-myc or one of the CK2 phosphorylation site variants using
Lipofectamine Plus reagent ( Invitrogen) according to the manufacturer’s protocol. The
cells were harvested 48 hr later in 200 µl of immunoprecipitation buffer (Lukov, Hu et al.
2005), and the PhLP-myc was immunoprecipitated from the lysate with 3 µg of anti-cmyc antibody and 30 µl of protein A/G beads as described previously (McLaughlin,
Thulin et al. 2002; Lukov, Hu et al. 2005). The final precipitate was solubilized in 40 µl
of 2X SDS-PAGE sample buffer, and 10 µl of each sample was resolved on 10% SDS-
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PAGE gels. The gels were immunoblotted with a 1:1000 dilution of the anti-c-myc
antibody and developed as described above.
Gβγ expression measurements – HEK-293 cells were plated in 6-well plates so that they
would be 70-80% confluent the following day. They were then co-transfected with 1 µg
of each of the PhLP-myc, HA-Gγ2, and Gβ1 cDNAs using Lipofectamine Plus reagent. In
all experiments involving multiple transfections, the total amount of cDNA was held
constant by adding empty vector. After 48 h, the cells were washed and solubilized in
200 µl of immunoprecipitation buffer. The Gβ1γ2 complexes were immunoprecipitated
from 100 µl of the lysate with 1.5 µg of anti-HA (clone 3F10, Roche Applied Science)
antibody as described previously (McLaughlin, Thulin et al. 2002; Lukov, Hu et al.
2005). The complexes were solubilized in 40 µl of 2X SDS sample buffer, and 10 µl was
resolved on 10% Tris-Tricine SDS-PAGE gels for Gβ1, or 20 µl was resolved on 16.5%
Tris-Tricine SDS-PAGE gels for Gγ2. For Gβ detection, the gels were immunoblotted
with a 1:2000 dilution of a Gβ1 antibody in the blocking buffer and then 1 h in a 1:2000
dilution of goat anti-rat horseradish peroxidase-conjugated secondary antibody
(Calbiochem). The immunoblots were developed as described above.
Radiolabel pulse-chase assay – The pulse-chase assay was performed and quantified as
described previously (Lukov, Hu et al. 2005). A similar protocol was used to measure the
rate of release of nascent Gβ from CCT. Six-well plates of HEK-293 cells were
cotransfected with 1 µg of FLAG Gβ1, HA-Gγ2 or PhLP-myc variants as indicated. After
a 10-min pulse, the radiolabel was chased for the times indicated and the cells were
harvested in 220 µl of immunoprecipitation buffer. The extract was divided into two 95
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µl samples, and 2.5 µl of 1 µg/µl anti-CCTε antibody (Serotec) was added to one sample
and 3.0 µl of 1 µg/µl anti-FLAG antibody was added to the other sample. The
immunoprecipitation and analysis of the radiolabeled proteins co-immunoprecipitating
with CCT were carried out as described (Lukov, Hu et al. 2005). The Gβ1 band was
clearly separated from the other radiolabeled bands, facilitating its quantification. The
amount of Gβ1 in the CCT immunoprecipitate was divided by that in the FLAG-Gβ1
immunoprecipitate to determine the fraction of the total Gβ1 bound to CCT. These values
were expressed as a percentage of the 30-min time point to readily compare the rates of
Gβ dissociation from CCT. The data were fit to a first order dissociation rate equation
using the KaleidaGraph graphics software to determine the dissociation rate constant k.
From the k values, the half-life was calculated by the equation, t1/2 = ln2/k.
Assay of Gβ binding to CCT – For CCT binding experiments involving Gβ1
overexpression, HEK-293 cells were plated in 6-well plates and transfected with 1.0 µg
of PhLP variants, and 1.5 µg of HA-Gγ as indicated in Fig. 5 (A and C). Alternatively, the
transfections were performed with 0.5 µg of FLAG-Gβ1, 1.0 µg PhLP variants, and 1.5
µg of HA-Gγ as indicated in Fig 6A. After 48 h, cells were lysed and extracts were
immunoprecipitated with 2.5 µg of anti-CCTε antibody (Serotec), the immunoprecipitates
were resolved on SDS-PAGE gels and immunoblotted for FLAG-Gβ1, PhLP-myc, Pdcmyc, or HA-Gγ2 using the indicated antibodies as described above, the intensities were
calculated as a percentage of the control as indicated.
For binding experiments involving endogenous Gβ, HEK-293 cells were grown in 100mm dishes and transfected with 6.0 µg of PhLP variant cDNAs as indicated in Fig. 5B.
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Cells were lysed in 1.2 ml of buffer, and 1 ml was immunoprecipitated with 10 µg of
anti-CCTε antibody and 60 µl of protein A/G beads. Endogenous Gβ1 was detected with
the anti-Gβ1 antibody. For binding experiments involving endogenous PhLP, HEK-293
cells were grown in 6-well plates and transfected with 1.0 µg of FLAG-Gβ1 cDNA as
indicated in Fig. 5C. Extracts from two wells were pooled, and 200 µl was
immunoprecipitated with 3 µg of anti-CCTε antibody. Other immunoprecipitation and
immunoblotting procedures were as described above.

RESULTS
Effects of CK2 phosphorylation of PhLP on CCT and Gβγ binding–To begin to assess the
impact of CK2 phosphorylation on PhLP function, the effects of phosphorylation on the
binding of PhLP to its two known binding partners, Gβγ and CCT, were determined in
vitro. Purified recombinant human PhLP was readily phosphorylated by CK2, resulting in
a marked reduction of the mobility of the PhLP protein band in SDS-PAGE gels (Fig.
1A). The entire PhLP band was shifted, indicating that phosphorylation was 100%
complete under the conditions used. The effects of CK2 phosphorylation on CCT binding
was assessed by measuring the ability of PhLP to co-immuno-precipitate CCT from
rabbit reticulocyte lysate (Martin-Benito, Bertrand et al. 2004). Human PhLP bound CCT
with a high affinity, as evidenced by the fact that addition of 5 nM PhLP was sufficient to
co-immuno-precipitate readily detectable amounts of CCT from rabbit reticulocyte lysate.
Under these conditions, CK2 phosphorylation increased the co-immunoprecipitation of
CCT by 7-fold (Fig. 1B). In contrast, CK2 phosphorylation had no effect on the ability of
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PhLP to co-immunoprecipitate purified Gβγ (Fig. 1B) or to inhibit association of Gβ1γ1
with Gtα and light-activated rhodopsin (Fig. 1C), indicating that phosphorylation did not
change the binding of PhLP to Gβ1γ1.

Fig. 3-1. Effects of CK2 phosphorylation on PhLP binding to CCT and Gβγ. (A) The decrease in
mobility of PhLP in SDS-PAGE upon CK2 phosphorylation is shown. PhLP was phosphorylated by
CK2 in vitro (P-PhLP) and was analyzed on a 10% gel along with unphosphorylated PhLP. (B) The
effects of CK2 phosphorylation on the binding of PhLP to CCT and Gβγ are shown. Binding was
measured by immunoprecipitation of PhLP coupled with detection of the co-immunoprecipitating
CCTε or Gβ by immunoblotting. A representative immunoblot is shown. The graph gives the average
intensity ± standard error of the CCT bands relative to the unphosphorylated sample from eight
separate experiments. (C) The effects of CK2 phosphorylation on the ability of PhLP to inhibit Gβ1γ1assisted binding of 125I-labeled Gτα to membranes containing light-activated rhodopsin were
determined. The graph gives the average ± standard error from three separate experiments.

Mass spectrometric analysis of the CK2 phosphorylation sites of PhLP – The
phosphorylation sites that could potentially be responsible for the increase in PhLP
binding to CCT upon CK2 phosphorylation were identified by mass spectrometry. PhLP
was phosphorylated by CK2 in vitro and digested with trypsin, and the resulting peptide
fragments were analyzed by electrospray tandem mass spectrometry. All mass spec
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experiments were performed by Michael Carter and Craig Thulin, and included for
completeness. Fig 2 shows the collision induced dissociation (CID) spectrum of a doubly
charged parent ion with an m/z ratio of 1198.5, corresponding to the mass of a tryptic
peptide containing the C-terminal residues 287–301 of PhLP plus one phosphate. This
CID spectrum showed robust peaks for both the b and y ions corresponding to the
sequence of the 287–301 peptide. Of these, the y16 ion had an m/z equal to the loss of a
phosphate, and the formation of a dehydroalanine at one of the two serines in this
fragment, indicating that either Ser-293 or Ser-296 was phosphorylated in the parent ion.
The b2, b4, b6, and b9 ions all had m/z ratios corresponding to the mass of their
unphosphorylated fragments, suggesting that Ser-288 and Ser-293 were not
phosphorylated. Therefore, the phosphate most likely resided on Ser-296. Accordingly,
Ser-296 is within a strong consensus site for CK2 phosphorylation with negatively
charged residues at the +1 and +3 positions (Meggio and Pinna 2003).
One other tryptic fragment with m/z values corresponding to a phosphorylated species
was detected and analyzed by CID. This peptide consisted of PhLP residues 13–32 plus
one and two phosphates. The spectrum for the singly phosphorylated species yielded few
b and y ions, none of which were phosphorylated. However, there were sufficient
fragments to confirm the identity of the peptide (Fig. 2B). The same result was obtained
with the doubly phosphorylated species. The CID spectrum confirmed the identity of the
peptide but did not show any phosphorylated fragments (Fig. 2C). Hence, the four serines
of this peptide, serines 18–20 and 25, could all be considered as potential CK2
phosphorylation sites.
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FIG. 3-2.Mass spectrometric analysis of the CK2 phosphorylation sites of PhLP. (A) PhLP was
phosphorylated by CK2 in vitro and digested with trypsin, and the resulting peptide fragments were
analyzed by LC/MS/MS. CID spectrum of the +2 parent ion corresponding to the m/z of the Cterminal sequence of PhLP plus one phosphate are indicated above the spectrum. The PhLP sequence
ends at Asp-301, and the additional residues (smaller font) are part of the linker for the C-terminal
myc tag of the recombinant human PhLP. The m/z values corresponding to the b and y ions resulting
from fragmentation of this peptide are indicated. The 1764 m/z peak corresponds to the y16 ion with
one dehydroalanine generated from the loss of H3PO4 from a phosphoserine during fragmentation. (B)
CID spectrum of the +2 parent ion corresponding to the m/z of residues 13-32 of PhLP plus one
phosphate. The m/z values corresponding to the b and y ions resulting from fragmentation of this
peptide are indicated. (C) CID spectrum of the +2 parent ion corresponding to the m/z of residues 1332 of PhLP plus two phosphates. The m/z values corresponding to the b and y ions resulting from
fragmentation of this peptide are indicated.
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Of the four, Ser-20 and Ser-25 are within CK2 consensus sites, and phosphorylation of
Ser-20 would create a strong consensus site for CK2 phosphorylation of Ser-19 in a
doubly phosphorylated species. Similarly, phosphorylation of Ser-19 would make Ser-18
a good CK2 site, although no triply phosphorylated species of the 18–32 peptide were
detected. Together, the mass spectrometric data suggest five potential CK2
phosphorylation sites on PhLP: Ser-18, Ser-19, Ser-20, Ser-25, and Ser-296.
Contribution of specific CK2 phosphorylation sites to the PhLP-CCT interaction – To
identify which of these sites is responsible for the phosphorylation-dependant increase in
PhLP binding to CCT, each of the five serines identified above was substituted with
alanine in various combinations. The resulting PhLP variants were CK2-phosphorylated,
and their binding to CCT was determined as described in Fig. 1. Substitution of one
residue within the serine 18–20 sequence caused only minor reductions in the
phosphorylation-induced increase in binding, whereas substitution of two residues within
this sequence resulted in reductions in the phosphorylation-induced binding from 7-fold
to ~4 fold (Fig. 3). Replacement of all three serines within this phosphorylation site
caused a further reduction in the phosphorylation-induced increase to 3-fold, indicating
that multiple phosphorylation events within the serine 18–20 sites were responsible for
much of the observed increase in PhLP binding to CCT upon CK2 phosphorylation. With
regard to the Ser-25 and Ser-296 sites, replacement of both residues caused a similar
modest decrease in binding as was seen with dual substitution within the serine 18–20
site, while replacement of either Ser-25 or Ser-296 along with all three of the Ser-18, Ser19, and Ser-20 residues was required to completely block the phosphorylation-induced
increase in binding.
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FIG. 3-3.Contribution of specific CK2 phosphorylation sites to the PhLP·CCT interaction. (A)
phosphorylation-induced increase in PhLP binding to CCT is shown for several PhLP variants with
the serine-to-alanine substitutions indicated. Binding of CCT to PhLP was determined for each variant
as in Fig. 1. Representative immunoblots for the phosphorylated (P) and unphosphorylated (NP)
variants are shown. (B) The -fold increase in CCT bound upon CK2 phosphorylation of PhLP was
calculated by dividing the CCTε band intensity of the phosphorylated sample by that of the
unphosphorylated sample. The graph gives the average increase ± standard error from three to five
separate experiments. (C) The shift in electrophoretic mobility of PhLP upon CK2 phosphorylation
was used to determine which of the putative CK2 sites were phosphorylated in cells. CHO cells were
transfected with the indicated PhLP variants with C-terminal myc epitope tags. After 48 h, the cells
were harvested and extracts were immunoprecipitated and immunoblotted with an antibody to the myc
tag. Phosphorylation of the variants was determined by the shift in mobility of the PhLP band
compared with wild-type PhLP-myc or purified, unphosphorylated PhLP-myc. (D) The
electrophoretic mobility of wild-type PhLP and the indicated PhLP variants after CK2
phosphorylation in vitro was also determined to compare the mobility shifts in vitro with those
observed in cells. PhLP variants were analyzed by SDS-PAGE gels as in Fig. 1.
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These results show that each of the five serines identified by mass spectrometry can
contribute to the phosphorylation-induced increase in PhLP binding to CCT and that no
other CK2 phosphorylation sites are involved in this process, suggesting that all the major
CK2 phosphorylation sites were identified in the mass spectrometric analysis.
It is important to note that the serine to alanine replacements did not change the binding
of unphosphorylated PhLP to CCT significantly (Fig. 3A), indicating that the alanine
substitutions did not affect the folding of the PhLP variants nor did they modify the
PhLP-CCT interaction significantly. Thus, the loss of the phosphorylation-induced
increase in binding with the multiple alanine substitutions could be attributed to an
inability of the variants to be phosphorylated by CK2.
Identification of specific CK2 phosphorylation sites in cells–To assess whether the CK2
phosphorylation sites of PhLP identified in vitro were also phosphorylated in vivo, the
decrease in electrophoretic mobility upon CK2 phosphorylation was exploited to detect
PhLP phosphorylation events in living cells. This work was completed by Georgi Lukov
and is included for completeness. In this experiment, PhLP serine to alanine substitution
variants with a C-terminal myc tag were transfected into CHO cells. Cells were extracted,
and the PhLP was immunoprecipitated and immunoblotted with an antibody to the tag to
distinguish the variants from the endogenous PhLP. Substitution of a serine that normally
would be phosphorylated by CK2 in wild-type PhLP would be expected to result in an
increase in mobility of that PhLP variant. Wild-type PhLP showed decreased mobility of
the entire band when compared with an unphosphorylated PhLP standard, indicating that
all of the transfected PhLP was phosphorylated in the CHO cells (Fig. 3C, upper panel).
The PhLP S20A variant showed two bands, a higher band with the same mobility as
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wild-type PhLP and a lower band with increased mobility. The ratio of the intensities of
the two bands was 2 to 1, with the higher band having the greater intensity. The PhLP
S18A and S19A showed a very small amount of the lower band, whereas S25A and
S296A showed no lower bands. The presence of both bands in the S20A variant suggests
that phosphorylation of Ser-18 or Ser-19 may be partially impaired when position 20
cannot be phosphorylated. These results indicate that Ser-20 is phosphorylated in cells
and that other phosphorylation events might also occur within the serine 18–20 sequence.
A similar analysis was done with double and triple serine to alanine substitutions (Fig.
3C, middle panel). The S18A/S19A/S20A variant showed a single lower band compared
with wild-type PhLP but that was still higher than the unphosphorylated control. The
S18A/S20A and S19A/S20A variants also showed a major lower band, with almost no
higher band corresponding to wild-type PhLP. The S18A/S19A variant showed both the
higher and lower bands, confirming phosphorylation at Ser-20 and indicating that it is
sufficient for the mobility shift. The two bands also suggest that Ser-20 phosphorylation
may be impaired in the absence of serine or phosphoserine at position 18 or 19. In the
case of the S25A/S296A variant, there was a single higher band with the same mobility as
wild-type PhLP, demonstrating that the large decrease in mobility is not a result of Ser-25
or Ser-296 phosphorylation, but rather it stems from at least one phosphorylation event in
the Ser-18, Ser-19, and Ser-20 sequence.
The mobility of PhLP variants substituted at four and all five sites was also determined.
The S18A/S19A/S20A/S25A variant causes an additional increase in the mobility of the
PhLP band to the same mobility as unphosphorylated PhLP, whereas the
S18A/S19A/S20A/S296A variant did not increase the mobility beyond that of serines 18–
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20. The variant in which all five sites were substituted has the same mobility as the
S18A/S19A/S20A/S25A variant and unphosphorylated PhLP. These data show that Ser25 is also phosphorylated in cells, at least in the absence of phosphorylation at serines 18–
20, and that Ser-25 phosphorylation causes a small decrease in PhLP mobility. The lack
of change in mobility with substitution of Ser-296 did not permit a conclusion to be made
about the phosphorylation of this site in cells. Either phosphorylation at Ser-296 did not
occur or it did not change the mobility of PhLP in SDS gels.
A very similar pattern of electrophoretic mobility shifts was observed with in vitro CK2
phosphorylation of the PhLP S/A variants (Fig. 3D). S18A/S19A/S20A showed increased
mobility compared with wild-type PhLP, and the S18A/S19A/S20A/S25A/S296A variant
had the same mobility as unphosphorylated PhLP. The similarities in mobility of the
PhLP variants between the in vitro phosphorylation and that found in cells argue that
CK2 is responsible for PhLP phosphorylation in vivo, in agreement with previous data
indicating that CK2 was the physiologically relevant kinase (Humrich, Bermel et al.
2003). Importantly, in the absence of CK2 phosphorylation, the S/A variants all had the
same mobility as unphosphorylated wild-type PhLP (data not shown), indicating that the
differences in mobility were not caused by the alanine substitutions. Together, these data
make a strong case for CK2 phosphorylation events within the serines 18–20 and 25 sites
in vivo.

Effects of specific CK2 phosphorylation sites on Gβγ expression and dimer assembly–It
has recently been reported that substitution of all three serine residues in the serine 18–20
sequence blocked the ability of PhLP to enhance the cellular expression of Gβγ
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(Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005). To further investigate this
phenomenon, the CK2 phosphorylation site variants of PhLP were coexpressed with Gβ1
and Gγ2 in HEK-293 cells, and the effects on Gβγ expression were measured by
immunoprecipitating the Gγ2 from cell extracts and immunoblotting for both Gβ1 and
Gγ2. This work was performed by Georgi Lukov, and is included for the purpose of
completeness. Co-expression of the single phosphorylation site variants did not change
Gβγ expression significantly compared with wild type, nor did co-expression of the
S18A/S19A or the S25A/S296A double variants (Fig. 4, A and B). However, coexpression of the S18A/S20A or the S19A/S20A double variants inhibited Gβ expression
by 60-70% and Gγ expression by 50% compared with wild type (Fig. 4A). Likewise, the
S18A/S19A/S20A triple variant inhibited Gβ and Gγ expression by 70-80% and 60-70%,
respectively (Fig. 4, A and B). Further substitution of Ser-25 and Ser-296 caused no
further decreases in Gβγ expression (Fig. 4B). These data clearly show that
phosphorylation of at least one serine within the serine 18–20 sequence is important for
PhLP to assist in the expression of Gβγ, with Ser-20 phosphorylation contributing the
most to this process. They also show that phosphorylation of Ser-25 and Ser-296 plays no
additional role in Gβγ expression. Moreover, the significant reduction in Gβγ expression
by several of the PhLP serine 18–20 variants to levels below those observed with the
empty vector indicate that these variants block the ability of endogenous PhLP to support
Gβγ expression and are thus acting as dominant negative inhibitors of Gβγ.
The reason for enhanced Gβγ expression in the presence of CK2-phosphorylated PhLP is
that phosphorylated PhLP increases the rate of Gβγ dimer assembly (Humrich, Bermel et
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al. 2005; Lukov, Hu et al. 2005). To determine which phosphorylation sites are critical
for PhLP-mediated Gβγ assembly, the ability of the PhLP CK2 phosphorylation site
variants to catalyze Gβγ dimer assembly was determined. All of the double and triple
variants of the serine 18–20 sequence were compromised in their ability to assist in Gβγ
dimer formation compared with wild-type PhLP (Fig. 4C). The S18A/S19A variant was
the least compromised, as reflected by an assembly half-life of 99 min compared with 42
min for wild-type PhLP, whereas the S18A/S19A/S20A variant was the most
compromised, with a half-life of 284 min (Fig. 4C). The S19A/S20A and S18A/S20A
variants showed intermediate half-lives of 153 and 128 min, respectively. In contrast, the
S25A/S296A variant was as effective as wild-type PhLP in promoting Gβγ assembly with
a half-life of 46 min. These Gβγ assembly results are qualitatively similar to the Gβγ
expression data. However, there is one significant quantitative difference in the
S18A/S19A variant between the Gβγ expression and the Gβγ assembly data. Gβγ
expression was only slightly reduced by the S18A/S19A variant, whereas the rate of Gβγ
assembly was reduced by >2-fold. This difference can be explained by the 48 hr time
period over which Gβγ expression was measured. It appears that the 2-fold reduction in
the rate of Gβγ assembly is sufficient to maintain the steady-state Gβγ levels achieved in
the 48 hr expression period to near those found in the presence of wild-type PhLP,
whereas the larger reduction in assembly observed with the other Ser-18, Ser-19, and Ser20 variants is not. Together, the Gβγ assembly and expression data indicate that two
phosphorylation events in the serine 18–20 sequence are required for PhLP to be fully
active in catalyzing Gβγ assembly. Phosphorylation at one of the three sites results in
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partial activity, with Ser-20 phosphorylation conferring the most activity. The results also
show that phosphorylation of Ser-25 or Ser-296 has no bearing on Gβγ assembly.
Gβ Binds CCT in a Ternary Complex with PhLP–The correlation between the increase in
binding of PhLP to CCT upon phosphorylation of serines 18–20 (Fig. 3B) and the
necessity of phosphorylation of serines 18–20 for full activity in Gβγ assembly (Fig. 4C)
suggests that the effects of PhLP phosphorylation on assembly may occur through CCT.
However, a role for CCT in Gβγ assembly has not been established (Humrich, Bermel et
al. 2005; Lukov, Hu et al. 2005). If CCT does participate in the assembly process, then it
must interact with Gβ, Gγ, or both. An interaction between Gβ and CCT has been
observed in yeast protein interaction screens, but no such interaction has been reported in
mammalian cells. Therefore, the binding of Gβ and Gγ to CCT was assessed by coimmunoprecipitation of overexpressed Gβ or Gγ in HEK-293 cells. This work was
performed by Christine Baker, and is included for the purpose of completeness. Gβ coimmunoprecipitated with CCT robustly, to a similar extent as overexpressed PhLP,
whereas overexpressed Pdc, which does not bind CCT, was not found in the CCT
immunoprecipitate (Fig. 5A). Thus, Gβ appears to be specifically interacting with CCT
under overexpression conditions. In contrast, over-expressed Gγ did not coimmunoprecipitate with CCT (Fig. 5A). To determine whether the interaction also
occurred with endogenous amounts of Gβ, the experiment was also done without
overexpressing Gβ. Co-immunoprecipitation of Gβ with CCT was also observed with
endogenous Gβ, confirming the results of the overexpression experiments (Fig. 5B).
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FIG. 3-4. Effects of PhLP phosphorylation on Gβγ expression and assembly. (A) Cellular
expression of Gβγ dimers was determined in the presence of PhLP S18A/S19A/S20A variants. HEK293 cells were transfected with Gβ1, HA-tagged Gγ2, and the indicated variants. The cells were
harvested, and extracts were immunoprecipitated with an antibody to the HA tag. The amount of HAGγ2 and co-immunoprecipitated Gβ1 was determined by immunoblotting with anti-HA and anti-Gβ1
antibodies. A representative blot is shown. The graph gives the average Gβ1 and HA-Gγ2 amounts ±
S.E. relative to wild-type PhLP from three separate experiments. Cells in the empty sample were
transfected with pcDNA3.1 vector with no PhLP cDNA. (B) Similar experiments were performed with
PhLP variants S25A and S296A separately and in combination with S18A/S19A/S20A. The data are
also combined from three separate experiments. (C) The rate of nascent Gβ1γ2 dimer formation in the
presence of CK2 phosphorylation site variants of PhLP was determined using a radiolabel pulse-chase
assay. Time measurements indicate the sum of the 10-min pulse and the variable chase periods. A
representative gel is shown. Band intensities were quantified, and molar ratios of Gβ1 to HA-Gγ2 were
calculated and plotted. Lines represent a fit of the data from three separate experiments to a first-order
rate equation. Values for t1/2 are shown next to the graph.
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The manner in which PhLP binds CCT at the top of the apical domains without entering
the folding cavity (Martin-Benito, Bertrand et al. 2004) suggests that PhLP, Gβ, and CCT
might form a ternary complex in the process of Gβγ folding. If such a ternary complex
does exist, then PhLP would be predicted to increase the binding of Gβ to CCT and vice
versa. To test this possibility, the effects of PhLP or Gβ overexpression on the binding of
the other to CCT was measured. As predicted, Gβ overexpression increased the binding
of endogenous PhLP to CCT (Fig. 5C). However, PhLP overexpression unexpectedly
caused a small but reproducible decrease in Gβ binding to CCT (Fig. 5B). It is possible
that this decrease in Gβ binding to CCT might be caused by PhLP-catalyzed Gβγ
assembly and release of the Gβγ dimer from CCT. To test this possibility, the effects of
two PhLP variants that do not support Gβγ assembly on Gβ binding to CCT were also
tested. One variant was PhLP S18A/S19A/S20A, and the other was a truncation variant in
which residues 1–75 had been removed (PhLP ∆1–75) (Humrich, Bermel et al. 2005;
Lukov, Hu et al. 2005). Both of these variants bind CCT, but they block Gβγ assembly in
a dominant negative manner (Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005).
Overexpression of either of these variants increased endogenous Gβ binding to CCT
dramatically (Fig. 5B). Thus, it appears that in the absence of serine 18–20
phosphorylation, PhLP forms a ternary complex with Gβ and CCT that cannot progress in
the assembly process. It is interesting to note that the PhLP ∆1–75 variant binds Gβγ very
poorly (Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005), yet it is still able to stabilize
the complex between Gβ and CCT. This observation indicates that PhLP ∆1–75 may do
so, more through interactions with CCT than through interactions with Gβ.
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FIG. 3-5.Gβ binds CCT in a ternary complex with PhLP. (A) binding of Gβ to CCT was detected
by co-immunoprecipitation. HEK-293 cells were transfected with FLAG-Gβ1, PhLP, Pdc, or HA-Gγ2,
and cell extracts were immunoprecipitated with an antibody to CCTε to bring down CCT complexes.
The immunoprecipitates were immunoblotted for Gβ1, PhLP, Pdc, or Gγ2. (B) The effects of PhLP on
the binding of endogenously expressed Gβ to CCT were measured by co-immunoprecipitation. HEK293 cells were transfected with wild-type PhLP, the PhLP S18A/S19A/S20A or ∆1-75 variants, or
empty vector. Cell extracts were immunoprecipitated with the anti-CCTε antibody and immunoblotted
for endogenous Gβ1. A representative immunoblot is shown. Bars in the graph represent the average ±
standard error of the Gβ band intensity relative to the empty vector control from four separate
experiments. (C) The effects of Gβ on the binding of endogenously expressed PhLP to CCT were also
measured by co-immunoprecipitation. HEK-293 cells were transfected with Gβ1, CCT was
immunoprecipitated as in panel B, and samples were immunoblotted for endogenous PhLP. A
representative immunoblot is shown. Bars in the graph represent the average ± standard error of the
PhLP band intensity relative to the empty vector control from three separate experiments.

PhLP phosphorylation is required for the release of Gβ from CCT and interaction with
Gγ–To further investigate the apparent correlation between the destabilization of the
PhLP·Gβ·CCT ternary complex by PhLP phosphorylation and the requirement for PhLP
phosphorylation in Gβγ assembly, the effects of Gγ on ternary complex formation with
several PhLP variants was measured. This work was performed by Georgi Lukov and
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Christine Baker, and is included for the purpose of completeness. Gβ was overexpressed
in HEK-293 cells with Gγ and PhLP variants as indicated, and the amount of Gβ coimmunoprecipitating with CCT was measured (Fig. 6A). Co-expression of Gγ caused a
decrease in Gβ binding to CCT that was intensified by the co-expression of wild-type
PhLP. In striking contrast, Gβ binding to CCT was greatly enhanced by co-expression of
PhLP ∆1-75 and was completely insensitive to co-expression of Gγ. Co-expression of
PhLP S18A/S19A/S20A also enhanced Gβ binding to CCT significantly, and Gγ had
much less of an effect on binding than with wild-type PhLP. Interestingly, the effects of
PhLP ∆1-75 and S18A/S19A/S20A on Gβ binding to CCT in the presence of Gγ were
quantitatively very similar to their effects on Gβγ assembly. PhLP ∆1-75 completely
blocked Gβγ assembly (Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005) and Gγmediated dissociation of Gβ from CCT, whereas PhLP S18A/S19A/S20A decreased the
rate of Gβγ assembly by 15-fold (Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005)
and Gγ-induced dissociation of Gβ from CCT by 9-fold (compare the Gβγ PhLP-WT
sample to the Gβγ PhLP S18A/S19A/S20A sample in Fig. 6A). From these data, it
appears that PhLP phosphorylation contributes to Gβγ assembly by enhancing the ability
of Gγ to release Gβ from the ternary complex.
There are two possible mechanisms by which phosphorylated PhLP could contribute to
Gγ-mediated release of Gβ from CCT. Both involve a conformational change in the
ternary complex upon PhLP phosphorylation. First, PhLP phosphorylation could induce a
conformation that allows Gγ to access Gβ in the ternary complex and form the Gβγ
dimer. The Gβγ would then be released from CCT. Second, phosphorylation could induce
53
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FIG. 3-6.PhLP phosphorylation is required for the release of Gβ from CCT and interaction with
Gγ. (A), the effects of PhLP phosphorylation and Gγ co-expression on Gβ binding to CCT were
measured by co-immunoprecipitation. HEK-293 cells were transfected with FLAG-Gβ1, HA-Gγ2, and
the PhLP variants as indicated. Cell extracts were immunoprecipitated with an antibody to CCTε and
then immunoblotted for FLAG-Gβ. A representative immunoblot is shown. Bars in the graph
represent the average ± S.E. of the Gβ band intensity relative to the Gβ/PhLP-WT sample from three
separate experiments. (B), the effects of PhLP phosphorylation on the rate of Gβ release from CCT
were measured using a radiolabel pulse-chase assay. HEK-293 cells were transfected with FLAG-Gβ1
and the indicated PhLP variants. The pulse-chase assay was performed as in Fig. 4C. After the chase
times indicated, cell extracts were immunoprecipitated with antibodies to CCTε or Gβ1. Proteins were
resolved by SDS-PAGE, and radiolabeled bands were detected using a Phosphorimager. The Gβ band
intensities were quantified, and ratios of nascent Gβ1 in the CCT immunoprecipitate versus the total
nascent Gβ in the Gβ immunoprecipitate were calculated and plotted as a percentage of the ratio at the
first time point. Lines represent a fit of the data from 3 separate experiments to a first-order rate
equation. Values for t1/2 are shown below the graph. (C), the effects of Gγ on PhLP-mediated release
of nascent Gβ1 from CCT were measured as in panel B in HEK-293 cells co-expressing HA-Gγ2 in
addition to FLAG-Gβ1 and PhLP. (D), the ability of Gγ to bind CCT was assessed by coimmunoprecipitation. HEK-293 cells were transfected with FLAG-Gβ1, HA-Gγ2, or PhLP variants as
indicated. Cells extracts were immunoprecipitated with an antibody to CCTε and then immunoblotted
for Gγ.A representative blot is shown. The Std lane in the CCT IP panel was the lysate from the Gγtransfected cells.

a conformation that releases PhLP·Gβ from CCT, thereby freeing the Gγ binding site on
Gβ for Gβγ association to occur. To distinguish between these two mechanisms, the
effects of Gγ and PhLP overexpression on the rate of dissociation of Gβ from CCT were
measured. In this experiment, cells co-expressing Gβ with Gγ, PhLP, or PhLP
S18A/S19A/S20A were pulsed with [35S]methionine for 10 min to label the nascent
polypeptides and then were chased with unlabeled methionine. At the times indicated, the
cells were lysed and CCT was immunoprecipitated. The co-immunoprecipitating proteins
were separated by SDS-PAGE, and the amount of 35S in the Gβ band was quantified. In
the absence of PhLP or Gγ co-expression, the dissociation rate of nascent Gβ from CCT
was very slow, with a t1/2 of ~8 h. PhLP co-expression increased the rate by 4-fold to a t1/2
of ~2 h. In contrast, PhLP S18A/S19A/S20A co-expression did not increase the
dissociation rate (Fig. 6B). When Gγ was co-expressed with Gβ, the dissociation rate
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increased by >2-fold to a t1/2 of ~3 h, whereas, when both Gγ and PhLP were coexpressed, the t1/2 increased even further to ~2 h, the same value observed in the absence
of Gγ overexpression (Fig. 6C). When PhLP S18A/S19A/S20A was co-expressed with
Gγ, there was essentially no Gβ dissociation, similar to what was seen in the absence of
Gγ overexpression (Fig. 6C). These effects of Gγ, PhLP, and PhLP S18A/S19A/S20A on
the dissociation rates are consistent with their effect on the steady-state binding of Gβ to
CCT (Fig. 6A) and further demonstrate that PhLP phosphorylation is required for the
release of Gβ from the ternary complex.
These findings are able to distinguish between the two potential mechanisms mentioned
above. For example, the enhanced rate of dissociation of Gβ from CCT upon PhLP
overexpression in the absence of Gγ overexpression (Fig. 6B) is consistent with the
second mechanism in which a phosphorylated PhLP·Gβ complex would be released prior
to Gγ binding to Gβ. This result would not be expected in the first mechanism in which
Gγ binding would be required for release of Gβ from CCT. Similarly, the observed lack
of increase in the Gβ dissociation rate upon co-expression of Gγ with PhLP would be
predicted by the second mechanism but not by the first. On the other hand, the increased
release of Gβ from CCT upon Gγ overexpression in the absence of PhLP overexpression
is consistent with the first mechanism, but this result could also be explained by the
second mechanism if the endogenous PhLP were acting catalytically to release Gβ from
CCT for association with Gγ. In this case, the dissociation process would be drawn
forward by the formation of the Gβγ dimer and its association with Gα and cell
membranes (Fig. 7). To further assess the role of Gγ in the release of Gβ from CCT, the
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FIG. 3-7.CK2 phosphorylation-dependent release model of Gβγ assembly. A model is proposed in
which nascent Gβ forms a ternary complex with CCT and PhLP. If PhLP is not phosphorylated, the
ternary complex is stable and PhLP·Gβ is not released from CCT. If PhLP is phosphorylated, the
ternary complex is destabilized, possibly by electrostatic repulsion between the phosphates in the
serine 18–20 phosphorylation site and negatively charged residues on the CCTα or -ε apical domains.
Once released, the PhLP·Gβ complex binds Gγ, forming the Gβγ dimer. The dimer then associates
with Gα and membranes in a manner yet to be defined. In the process, PhLP is released to catalyze
another round of dimer formation. The approximate position of the serine 18–20 phosphorylation site
is depicted by a red oval marked `P.' The relative amount of positive and negative charges on the CCT
apical domains that contact the PhLP N-terminal domain is also indicated.

possible association of Gγ with Gβ and PhLP in CCT complexes was determined. Gγ was
co-expressed with the indicated combinations of Gβ and the PhLP variants, the CCT
complexes were immunoprecipitated, and the samples were immunoblotted for Gγ. Gγ
was not found in any of the CCT immunoprecipitates (Fig. 6D), despite the fact that Gβ
and PhLP could be readily found under these conditions (see Fig. 5). Thus, it appears that
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Gγ does not interact with CCT in any of its complexes with Gβ and PhLP. Together, the
data in Fig. 6 indicate that PhLP phosphorylation results in the release of a PhLP·Gβ
complex from CCT that can then associate with Gγ to form the Gβγ dimer. This
conclusion is also supported by the previously reported observation that PhLP forms a
stable complex with Gβ that does not include Gγ (Lukov, Hu et al. 2005).

DISCUSSION
A model for Gβγ assembly–Recent studies have shown that PhLP acts as an essential
chaperone in the assembly of Gβγ dimers by binding the Gβ subunit and thereby allowing
Gγ to associate with Gβ (Humrich, Bermel et al. 2005; Lukov, Hu et al. 2005).
Phosphorylation of PhLP at serines 18–20 by CK2 was required for Gβγ assembly to
occur, yet the means by which phosphorylation of serines 18-20 contributes to assembly
was unknown. Moreover, CCT had been implicated in the assembly process, but the
results were conflicting (Martin-Benito, Bertrand et al. 2004; Humrich, Bermel et al.
2005; Lukov, Hu et al. 2005). The current study provides evidence for a molecular
mechanism describing both the role of CCT and PhLP phosphorylation in Gβγ assembly
(Fig. 7). There are five important steps in this mechanism: 1) the nascent Gβ polypeptide
binds CCT. This is a stable complex that releases Gβ very slowly in the absence of PhLP.
2) PhLP binds forming a ternary complex. If PhLP is not phosphorylated, then the ternary
complex forms in a stable conformation that does not release PhLP·Gβ, and the Gβγ
assembly process is blocked. However, if PhLP is dually phosphorylated within the serine
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18–20 sequence, then the ternary complex assembles in a conformation that readily
releases the PhLP·Gβ dimer. 3) PhLP·Gβ dissociates from CCT. The structure of the
Pdc·Gτβγ complex shows that Pdc binds Gβ on the opposite face as Gγ (Gaudet, Bohm et
al. 1996), predicting that the Gγ binding site on Gβ would be free in the PhLP·Gβ dimer.
4) Gγ binds Gβ forming a PhLP·Gβγ complex. This complex is stable with a 100 nM
binding affinity (Savage, McLaughlin et al. 2000). However, both the Gα binding site
and the membrane association surface of Gβγ overlap extensively with the PhLP binding
site (Savage, McLaughlin et al. 2000); therefore in the presence of Gα and membranes,
PhLP would be expected to be released from Gβγ. 5) Gβγ associates with Gα and/or the
endoplasmic reticulum membrane and is transported to the plasma membrane
(Michaelson, Ahearn et al. 2002). PhLP is then free to catalyze another round of Gβγ
assembly.
This model readily explains the dominant negative effect of the PhLP S18A/S19A/S20A
and PhLP ∆1-75 variants. These variants form PhLP·Gβ·CCT ternary complexes that do
not release PhLP·Gβ for Gγ binding. Such stable ternary complexes would also block the
endogenous, phosphorylated PhLP from forming competent ternary complexes capable of
releasing PhLP·Gβ for Gγ binding. Previous explanations of the dominant negative effect
of PhLP S18A/S19A/S20A, which postulated that unphosphorylated PhLP would block
Gβ and Gγ association with CCT (Humrich, Bermel et al. 2005) or that unphosphorylated
PhLP would form a PhLP·Gβ complex that would not accept Gγ (Lukov, Hu et al. 2005),
are incomplete.

59

Phosphorylation-induced conformational changes—One apparent inconsistency in the
data is that CK2 phosphorylation of PhLP increased its binding to CCT in the absence of
Gβ (Fig. 1), yet PhLP phosphorylation was necessary for the release of PhLP·Gγ from
CCT in the presence of Gβ (Figs. 4, 5, and 6). The difference between these observations
may stem from differences in the structures of the PhLP·CCT and PhLP·Gβ·CCT
complexes. Clues regarding the nature of the phosphorylation-dependent changes in these
structures may be gleaned from the cryoelectron microscopic studies of the
unphosphorylated PhLP·CCT complex (Martin-Benito, Bertrand et al. 2004). In this
complex, PhLP was shown to interact in two distinct conformations at the top of the CCT
toroid, contacting only the CCT apical domains (Martin-Benito, Bertrand et al. 2004). In
one conformation, the N-terminal phosphorylation site of PhLP was in close proximity to
the CCTα and -ε apical domains and in the other conformation the phosphorylation site
was in close proximity to the CCTζ and -β apical domains. The binding surfaces of all
eight apical domains are dominated by charged and polar residues (Pappenberger,
Wilsher et al. 2002) with the CCTα and -ε binding surfaces having a high distribution of
negative charge, whereas the CCTζ binding surface exhibits an extensive positively
charged patch. The serine 18–20 phosphorylation site of PhLP is harbored within a
sequence (18SSSDEDESD26) that is already very negatively charged. The addition of
phosphates within this sequence would create an extremely high concentration of
negative charge that would interact effectively with the positively charged patch of CCTζ.
In the absence of Gβ, phosphorylation could favor the conformation that brings the PhLP
phosphorylation site in close proximity to the CCTζ apical domain, increasing the
binding of PhLP to CCT. In the presence of Gβ, it is possible that interactions with Gβ
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may limit the ability of PhLP to rotate on the top of the CCT toroid. Thus, the
phosphorylation site may be fixed in close proximity to the CCTα and -ε apical domains,
causing electrostatic repulsion between the negative charges on the CCTα and -ε binding
surfaces and the PhLP phosphorylation site. This repulsion might destabilize the ternary
complex and allow the release of the PhLP·Gβ complex. Further studies will be required
to test the validity of this structural model.
Regulation of CK2 Phosphorylation of PhLP–Given the essential role of CK2
phosphorylation of PhLP in Gβγ dimer formation, an important issue yet to be addressed
is the regulation of this phosphorylation event. CK2 is a constitutively active kinase with
many protein substrates (Litchfield 2003). Determination of which substrates are
phosphorylated and when phosphorylation occurs appears to be controlled by regulated
expression and assembly of the CK2 α2β2 tetramer and by the association of different
CK2 binding partners (Litchfield 2003). In the case of PhLP, CK2 phosphorylation
occurs within the first 30 min of its synthesis (data not shown), and it remains completely
phosphorylated under the cell culture conditions used here (Fig. 2). It is not clear from the
current data whether phosphorylation occurs prior to or after association of PhLP with
CCT (Fig. 7). In mouse tissues, PhLP was also completely phosphorylated in brain and
heart but was mostly unphosphorylated in the adrenal gland (Humrich, Bermel et al.
2003). It is possible that Gβγ assembly is a continuous process in some cell types,
whereas in others assembly is highly regulated, only occurring under certain conditions
that promote CK2 phosphorylation of PhLP.
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These investigations into the mechanism of PhLP-mediated Gβγ assembly and its
regulation by CK2 phosphorylation suggest that PhLP and its interactions with Gβ and
CCT could be targeted by therapeutics to control the levels of Gβγ expression and thus
the degree of G protein signaling within the cell, perhaps providing additional tools to
treat the myriad of G protein-linked diseases.
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CHAPTER 4
PURIFICATION OF THE G PROTEIN β SUBUNIT, PHOSDUCIN-LIKE
PROTEIN, AND THE CYTOSOLIC CHAPERONIN TERNARY
COMPLEX
Introduction–Initial reports describing the interaction between PhLP and its binding
partners CCT and Gβγ postulated the role of PhLP may be to regulate G protein signaling
by sequestering Gβγ from Gα and its effectors, or conversely that CCT may regulate G
protein signaling by sequestering PhLP (Bauer, Muller et al. 1992; Lee, Ting et al. 1992;
Hawes, Touhara et al. 1994; Gaudet, Bohm et al. 1996). This role of PhLP as a negative
regulator of G protein signaling followed well the role of Phosducin (Pdc), which has
been reported to act as a negative regulator of G protein signaling by sequestering the G
protein βγ subunit from the outer segment in light-activated photoreceptor rod cells
(Sokolov, Strissel et al. 2004). However, initial reports on the role of PhLP as a negative
regulator were inconclusive and the significance of its interactions with its binding
partners initially remained elusive. In addition, several inconsistencies arose in the
sequestration model. First, expression levels of PhLP were reported to be significantly
lower than that of Gβγ (Schroder and Lohse 2000) and most data showing down
regulation of G protein signaling required significant overexpression of PhLP, raising
doubts about the ability of PhLP to sequester enough Gβγ in order to have an effect on G
protein signaling under physiological conditions. Second, evidence suggested PhLP to be
constitutively bound to Gβγ with no apparent mechanism of regulation (Thulin, Howes et
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al. 1999). Third, strong evidence suggesting the role of PhLP as a positive regulator of G
protein signaling came from two separate studies showing that deletion of the PhLP1
gene in chestnut blight fungus Cryphonectria parasitica (Kasahara, Wang et al. 2000)
and in Dictyostelium discoideum (Blaauw, Knol et al. 2003) abolished G protein
signaling and yielded the same phenotype as deletion of the Gβ gene.
Further insight into the role of PhLP emerged from structural and biochemical studies of
PhLP bound to CCT. The structure of the PhLP·CCT complex obtained from cryo
electron microscopy studies showed that PhLP sits above the CCT folding cavity,
contacting the apical domains of the CCT subunits and occluding the entrance into the
cavity similar to that of prefoldin, a co-chaperonin required for actin and tubulin folding
(Martin-Benito, Bertrand et al. 2004). In addition it has been shown that PhLP does not
bind CCT as a folding substrate, but rather binds CCT in its native form, suggesting a
regulatory role for PhLP as a co-chaperonin (McLaughlin, Thulin et al. 2002).
The strongest evidence so far for the role of PhLP comes from data which shows that
PhLP is an essential chaperone in the formation of the Gβγ dimer (Lukov, Hu et al.
2005). In this report, it was shown that Gβ1 expression dropped 40% without affecting
Gβ1 mRNA levels when PhLP1 expression was inhibited using RNA interference. In
addition, PhLP1 depletion inhibited histamine-mediated increases in cytosolic Ca2+ via
Gq by 60%. This reduction in Gβ1 expression and G protein signaling suggests a critical
role for PhLP in the formation of the Gβγ dimer.
The most recent findings show that PhLP forms a ternary complex with Gβ and CCT and
that phosphorylation of PhLP within the S18–20 sequence is required for the release of
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Gβ from CCT (Lukov, Baker et al. 2006). Furthermore, it was shown that the rate of
release of Gβ from CCT was not increased by overexpressing Gγ, suggesting that the
PhLP·Gβ complex dissociates from CCT prior to Gγ binding to Gβ to form the Gβγ
complex. In addition, it has been shown that Gβ binds CCT prior to its interaction with
Gγ and that the ATPase cycle of CCT was necessary for Gβ release, enabling its
association with Gγ (Wells, Dingus et al. 2006).
Together these data suggest an important role for PhLP in Gβγ dimer assembly. In order
to better understand the mechanism of Gβγ dimer assembly and the role of
phosphorylation within the S18–20 sequence of PhLP, the PhLP·Gβ·CCT ternary
complex was expressed and purified from insect cells for x-ray crystallographic and cryo
electron microscopy structural studies.

EXPERIMENTAL PROCEDURES

Construction of recombinant transfer vector for PhLP-TEV-myc-His–The cDNA for the
wild-type human PhLP with a 3´ c-myc and His6 tag was previously constructed in the
pcDNA 3.1/myc-His B vector (Lukov, Hu et al. 2005). A pBlueBac4.5 vector encoding a
C-terminal TEV protease cleavable myc-His6 tag was constructed by introducing the
TEV protease site into the cDNA using PCR. The T7-forward primer site of pcDNA3.1
was used with a reverse primer encoding an XbaI restriction site (underlined), with the 7
amino acids of the TEV protease site (ENLYFQG) and the C-terminal sequence of
human PhLP (5´-CCG CGG GCC CTC TAG ACC CTG AAA ATA CAA ATT CTC
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ATC TAT TTC CAG GTC GCT ATC CTC-3´). The expected 1,025-bp of PCR product
was purified on 1% TE agarose gel and digested with EcoRI and XbaI. The expected 929
bp DNA fragment was purified and cloned into EcoRI/XbaI sites of pcDNA3.1 vector
and its sequence was confirmed. The open reading frame of PhLP-TEV-myc-His was
PCR amplified using the T7-forward primer and BGH reverse primer sites of
pcDNA3.1/myc-His B vector. The expected 1,131-bp PCR product was purified on 1%
TE agarose gel and digested with BamHI and AgeI. The expected 1,006-bp fragment was
purified and cloned into BamHI/AgeI sites of pBlueBac4.5 vector and its sequence was
confirmed.

Construction of recombinant transfer vector for Gβ1-HPC4–A pBlueBac4.5 vector
encoding C-terminal HPC4 epitope-tagged Gβ1 was constructed by introducing the HPC4
epitope into the cDNA using PCR. The cDNA for the wild-type human Gβ1 in the
pcDNA3.1 vector was obtained from the University of Missouri-Rolla cDNA Resource
Center. The T7-forward primer was used with a reverse primer encoding an XbaI
restriction site (underlined), the 12 amino acids of the HPC4 epitope
(EDQVDPRLIDGK) and the C-terminal sequence of human Gβ1, (5´-CGT ACT CTA
GAT TAC TTG CCG TCG ATC AGC CTG GGG TCC ACC TGG TCC TCG TTC
CAG ATC TTG AGG AAG CTA TCC CAG G-3´). The expected 3,255-bp of PCR
product was purified on a 0.7% TE agarose gel and digested with BamHI and XbaI. The
expected 3,191-bp DNA fragment was purified and cloned into the BamHI/XbaI sites of
pBlueBac4.5 vector and its sequence was confirmed.
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Production of recombinant baculoviruses containing PhLP-TEV-myc-His and Gβ1HPC4–pBlueBac4.5- PhLP-TEV-myc-His and pBlueBac4.5- Gβ1-HPC4 constructs were
co-transfected with linearized Bac-N-Blue™ viral DNA (AcMNPV, Autographa
californica multiple nuclear polyhedrosis virus) in the presence of Cellfectin™ reagent
insect cell-specific liposomes, into Spodoptera frugiperda (Sf9) insect cells (Invitrogen).
The recombinant baculovirus was identified and purified by plaque assay and the putative
recombinant plaques were transferred to 12-well microtiter plates and amplified in sf9
cells. Viral DNA was purified for PCR analysis to determine the purity of recombinant
viruses. High titer viral stocks were generated by amplification in sf9 cell suspension
cultures according to the manufacturer’s instructions.
Expression of PhLP-TEV-myc-His and Gβ1-HPC4 in insect cells–High Five™ cells
(Invitrogen) were cultured at 27°C in EX-CELL™ 405 serum-free medium (SAFC
Biosciences) supplemented with 100 units of penicillin-streptomycin/ml (Gibco) in
culture spinner flasks with constant stirring at 80 rev/min. When the cell density reached
2 X 106 cells/ml, they were inoculated with high titer viral stocks of the PhLP-TEV-mycHis and G protein β1-HPC4 expressing recombinant baculoviruses at a multiplicity of
infection of 15 viral particles per cell.
Purification of complexes containing PhLP, Gβ1, and CCT–All purification steps were
conducted at 4°C with ice-cold buffers supplemented with 1 mM phenylmethylsulfonyl
fluoride. Cells were harvested 84 hours after baculovirus inoculation by adding 1:20
Insect PopCulture™ (Novagen) lysis reagent to the cell culture and stirring for 20
minutes. Lysate was centrifuged at 3,500g for 10 min, after which the supernatant was
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treated with 25KU of Benzonase Nuclease HC (Novagen)/150ml supernatant and
dialyzed overnight in dialysis buffer (20 mM HEPES, pH 8.0, 20mM NaCl, and 2mM
MgCl2, 0.05% CHAPS). Following dialysis, the lysate was loaded onto a Ni-NTA
agarose (Invitrogen) column, washed with 4 column volumes of dialysis buffer, and the
complex eluted with Ni-NTA elution buffer (20 mM HEPES, pH 7.0, 150 mM NaCl,
500 mM imidazole, 0.05% CHAPS). The elutant off the Ni-NTA column was
supplemented with 2 mM Ca2+ and then loaded onto an HPC4 affinity agarose (Roche
Applied Sciences) column equilibrated with equilibration buffer (20 mM HEPES, pH 7.5,
250 mM NaCl2, 2 mM CaCl2). The column was washed with HPC4 equilibration buffer,
and the complex was eluted with HPC4 elution buffer (20 mM HEPES, pH 7.5, 500 mM
NaCl, 10 mM EDTA, 0.05% CHAPS).
Analysis of the purified ternary complex by SDS-PAGE and immunoblotting–To
determine the purity of the HPC4 eluant and to confirm the presence of PhLP and Gβ1,
15 µl of eluant off the HPC4 affinity column was electrophoresed on an SDS/PAGE gel
(10%) with 5 µl of 4X Laemmli sample buffer and either Coomassie stained or
transferred to nitrocellulose membrane for immunoblotting. Membranes were
immunoblotted with rabbit antiserum against the N-terminal 50 amino acids of PhLP and
the N-terminal 15 amino acids of Gβ1. Dilutions for primary antibodies were as follows:
anti PhLP, 1:5,000; anti-Gβ1, 1:2,500. The blots were incubated in goat anti-rabbit
secondary antibody at a dilution of 1:10,000 for 1 hr at 4°C and developed using an
Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE).
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Mass spectrometric analysis of purified Gβ1, PhLP, and CCT ternary complex– In order
to confirm the identity of the individual bands and the existence of CCT in the eluant, gel
bands were excised and identified using electrospray tandem mass spectrometry
(LCMSMS). Fifteen microliters of elutant off the HPC4 affinity column was
electrophoresed on an SDS/PAGE gel (10%) with 5 µl of 4X Laemmli sample buffer and
Coomassie stained. Bands were excised, in-gel digested as described previously
(Shevchenko, Wilm et al. 1996), and injected onto a C18 reversed-phase resin capillary
column and eluted using a gradient of 5 to 95% acetonitrile in 0.1% formic acid.
Fragmentation spectra were analyzed using BioAnalyst software (Applied Biosystems,
Farmingham, MA). Collision induced dissociation (CID) spectra for the three most
intense ions from each scan were selectively chosen and submitted to the Mascot (Matrix
Science) website for peptide identification.

RESULTS
Purification of the PhLP·Gβ1·CCT ternary complex– High Five TM insect cells
(Invitrogen) were inoculated with high titer viral stock of PhLP-TEV-myc-His and Gβ1HPC4-expressing recombinant baculovirus. PhLP·Gβ1·CCT ternary complexes from the
cell culture were purified using Ni2+ affinity chromatography followed by further
purification with an immobilized HPC4 antibody column as described in Experimental
Procedures. A Coomassie-stained gel of the purified product revealed bands at ~38kDa
and ~45kDa along with a cluster of bands around ~60–65kDa, which correspond to the
molecular weights of Gβ1, PhLP, and CCT subunits respectively (Fig 1). The 38 kDa
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PhLP-myc-His standard

Purified PhLP-TEV-myc-His

Untagged Gβ Standard

Purified Gβ-CCT

M.W. Standards

Purified Gβ-CCT

←118 KDa
←85 KDa
CCT Subunits {
← 47 KDa

PhLP-TEV-myc-His→
Gβ HPC4→

←36 KDa
←26 KDa
←20 KDa
SDS-PAGE

Gβ I.B.

PhLP I.B.

Fig. 4-1. Purufication of the Gβ
β ·CCT·PhLP complex. The SDS-PAGE gel shows the HPC4tagged Gβ, PhLP, and a cluster of CCT bands. Immunoblots confirm the identity of the PhLP
and Gβ bands.

band was recognized by a Gβ1 antibody and the 45 kDa band was recognized by a PhLP
antibody in immunoblots (Fig. 1). No antibodies were available against insect cell CCT
subunits and therefore mass spectrometry was used to identify the 60-65 kDa cluster of
bands. Gel bands were excised, in-gel digested with trypsin and prepared for mass spec
analysis. Good quality CID spectra (defined as spectra with a P value<0.05) for six of the
seven bands were obtained, while sample from band #5 did not yield credible protein
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118KDa→

85 KDa→

←band #1
←band #2
}- band #3
←band #4
47 KDa→

}- band #5
←band #6

←band #7
36 KDa→

26 KDa→

Fig. 4-2. Mass spectrometric identification of proteins in the purified complex. The product off the
HPC4 column was analyzed by SDS-PAGE and the gel bands were excised and in-gel digested with
trypsin. The cleaved peptides were then analyzed by LCMSMS and their parent proteins were identified by
searching the NCBI non-redundant protein database using the Mascot program. The table gives the identity
of the bands. Numeric values indicate the probability score for a given identification with higher scores
indicating greater confidence. Generally probability scores in the 30-40 range gave p < 0.05, and all of
these identifications were well within the p < 0.05 limit.

Band
1
2
3
4
5
6
7

Identity
Albumin
CCTζ, CCTγ
CCTα, CCTβ
CCTη
No I.D.
PhLP1
Gβ1
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Mascot score
200
169, 87
134, 153
55
68
144

identification. Band #1 was identified as albumin (Fig. 2.). Bands 2, 3 and 4 were
identified as CCT bands with band 2 containing CCT subunits ζ and γ, band 3 containing
CCT α and β, and band 4 containing the CCT η. Bands 6 and 7 were identified as human
PhLP and Human Gβ1. The Mascot scores for each band are shown in Fig. 2. These
results indicate that a complex between CCT, PhLP and Gβ1 was purified with only
minor impurities. Final yields of the complex were typically in the range of 500-900 µg
of total protein from 500 ml of cell culture.

DISCUSSION
Recently published data show that PhLP forms a ternary complex with Gβ and CCT in
the process of Gβγ assembly and that phosphorylation of PhLP within the S18–20
sequence is necessary for the release of a PhLP-Gβ intermediate from CCT for
association of Gβ with Gγ (Lukov et al. 2006). In order to understand the structural
mechanism by which phosphorylation of PhLP destabilizes the PhLP·Gβ·CCT ternary
complex, we have purified the complex for cryo-electron microscopic and x-ray
crystallographic structural studies. We have shown that it is possible to obtain sufficient
quantities of the complex for cryo electron microscopy (~ 100 µg protein). However, in
order to begin X-ray crystallography studies, a higher quantity of sample (>5 mg protein)
and an additional purification step such as gel-filtration will be required. In order to
obtain higher yields, scale-up of the purification will be necessary. The efficiency of the
purification suggests that simply increasing the volume of insect cell culture and the size
of the affinity columns may be sufficient to obtain the necessary yields.
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The results of this purification further confirm previous data suggesting the existence of a
ternary complex between PhLP, Gβ, and CCT. Now that the ternary complex is isolated,
the cryo-EM and X-ray crystallographic structural determinations can proceed in earnest.
By comparing the structures of the ternary in both states of PhLP phosphorylation, the
mechanism by which S18-20 phosphorylation triggers the release of PhLP-Gβ will be
revealed. In addition, X-ray determinations will show the atomic structure of the CCT
complex for the first time, elucidating the ways in which this multi-subunit complex
functions so elegantly to catalyze the folding of its protein substrates. Previous attempts
to crystallize CCT have been unsuccessful, probably because of the flexibility of the
apical domains. The formation of the PhLP-Gβ-CCT complex will decrease this
flexibility as a result of the contacts between PhLP and the CCT apical domains and
should increase the chances of obtaining stable crystals significantly. Determination of
the structure of the PhLP-Gβ-CCT complex would represent a major breakthrough in the
understanding of protein folding by CCT and the co-chaperoning role of PhLP in this
process.
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